,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,446537,4477,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,357,2,1,,11111533,4477,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
2,357,2,1,,11111534,4477,Inconclusive,,,,,AP1 Signaling Pathway,Confirmatory,,
3,410,1,5,,11111533,4477,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
4,410,1,5,,11111534,4477,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
5,411,2,1,,11111533,4477,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
6,411,2,1,,11111534,4477,Inconclusive,160794.0,,10.0,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
7,422,1,5,,17405839,4477,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
8,429,1,5,,17405839,4477,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
9,429,1,5,,17405839,4477,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
10,436,2,1,,17405839,4477,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
11,444,1,1,,11111533,4477,Active,,,,,NFAT Signaling Pathway,Confirmatory,,
12,444,1,1,,11111534,4477,Active,,,,,NFAT Signaling Pathway,Confirmatory,,
13,445,3,1,,11111533,4477,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
14,445,3,1,,11111534,4477,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
15,446,1,1,,11111533,4477,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
16,446,1,1,,11111534,4477,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
17,447,1,1,,11111533,4477,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
18,447,1,1,,11111534,4477,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
19,448,1,2,,11111533,4477,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
20,448,1,2,,11111534,4477,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
21,450,1,2,,11111533,4477,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
22,450,1,2,,11111534,4477,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
23,451,1,2,,11111533,4477,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
24,451,1,2,,11111534,4477,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
25,526,1,1,,11111533,4477,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
26,526,1,1,,11111534,4477,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
27,530,1,1,,11111533,4477,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
28,530,1,1,,11111534,4477,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
29,547,1,4,,17405839,4477,Active,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
30,584,1,3,,11111533,4477,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
31,584,1,3,,11111534,4477,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
32,585,1,4,,11111533,4477,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
33,585,1,4,,11111534,4477,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
34,587,1,5,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
35,587,1,5,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
36,588,1,4,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
37,588,1,4,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
38,589,1,3,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
39,589,1,3,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
40,590,1,3,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
41,590,1,3,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
42,591,1,4,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
43,591,1,4,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
44,592,1,6,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
45,592,1,6,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
46,593,1,4,,11111533,4477,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
47,593,1,4,,11111534,4477,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
48,594,1,4,,11111533,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
49,594,1,4,,11111534,4477,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
50,595,1,3,,11111533,4477,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
51,595,1,3,,11111534,4477,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
52,596,1,2,,11111533,4477,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
53,596,1,2,,11111534,4477,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
54,597,1,3,,11111533,4477,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
55,597,1,3,,11111534,4477,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
56,603,1,2,,11111533,4477,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
57,603,1,2,,11111534,4477,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
58,605,1,2,,11111533,4477,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
59,605,1,2,,11111534,4477,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
60,607,1,3,,11111533,4477,Inconclusive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
61,607,1,3,,11111534,4477,Inconclusive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
62,662,1,1,,11111533,4477,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
63,662,1,1,,11111534,4477,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
64,694,1,1,,17405839,4477,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
65,732,1,2,,17405839,4477,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
66,875,1,2,,11111533,4477,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
67,875,1,2,,11111534,4477,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
68,875,1,2,,26747596,4477,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
69,879,1,2,,11111533,4477,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
70,879,1,2,,11111533,4477,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
71,880,2,1,,11111534,4477,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
72,880,2,1,,11111534,4477,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
73,880,2,1,,26747596,4477,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
74,880,2,1,,26747596,4477,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
75,880,2,1,,26753613,4477,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
76,880,2,1,,26753613,4477,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
77,880,2,1,,50106712,4477,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
78,880,2,1,,50106712,4477,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
79,881,2,2,,11111533,4477,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
80,881,2,2,,11111534,4477,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
81,881,2,2,,26747596,4477,Inconclusive,317373425.0,247.0,0.1585,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
82,883,1,3,,11111533,4477,Active,13699818.0,1559.0,2.5119,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
83,883,1,3,,11111534,4477,Active,13699818.0,1559.0,0.631,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
84,884,1,2,,11111533,4477,Inconclusive,13435386.0,1576.0,2.5119,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
85,884,1,2,,11111534,4477,Active,13435386.0,1576.0,3.1623,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
86,884,1,2,,26747596,4477,Active,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
87,885,1,2,,11111533,4477,Inactive,13435386.0,1576.0,2.5119,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
88,885,1,2,,11111534,4477,Inactive,13435386.0,1576.0,3.1623,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
89,885,1,2,,26747596,4477,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
90,886,1,2,,11111533,4477,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
91,886,1,2,,11111533,4477,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
92,886,1,2,,11111534,4477,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
93,886,1,2,,11111534,4477,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
94,887,1,2,,11111533,4477,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
95,887,1,2,,11111534,4477,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
96,887,1,2,,26747596,4477,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
97,889,1,3,,11111533,4477,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
98,889,1,3,,11111534,4477,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
99,889,1,3,,26747596,4477,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
100,891,1,2,,11111533,4477,Active,40805836.0,1565.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
101,891,1,2,,11111534,4477,Inactive,40805836.0,1565.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
102,892,1,2,,11111533,4477,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
103,892,1,2,,11111534,4477,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
104,892,1,2,,26747596,4477,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
105,893,1,2,,11111533,4477,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
106,893,1,2,,11111533,4477,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
107,893,1,2,,11111534,4477,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
108,893,1,2,,11111534,4477,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
109,893,1,2,,26747596,4477,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
110,893,1,2,,26747596,4477,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
111,894,2,1,,11111534,4477,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
112,894,2,1,,26747596,4477,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
113,894,2,1,,50106712,4477,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
114,895,1,2,,11111533,4477,Inconclusive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
115,899,1,2,,11111533,4477,Inactive,4503219.0,1557.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
116,899,1,2,,11111534,4477,Inconclusive,4503219.0,1557.0,0.3981,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
117,900,1,3,,11111533,4477,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
118,900,1,3,,11111534,4477,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
119,900,1,3,,26747596,4477,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
120,901,1,2,,11111533,4477,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
121,901,1,2,,11111534,4477,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
122,902,1,2,,11111533,4477,Active,120407068.0,7157.0,0.5012,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
123,902,1,2,,11111534,4477,Inconclusive,120407068.0,7157.0,1.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
124,902,1,2,,26747596,4477,Active,120407068.0,7157.0,3.9811,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
125,910,1,2,,26747596,4477,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
126,912,1,2,,11111533,4477,Inconclusive,21392848.0,,0.5012,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
127,912,1,2,,11111534,4477,Active,21392848.0,,0.2512,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
128,914,1,3,,11111533,4477,Inconclusive,32879895.0,3091.0,2.5119,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
129,914,1,3,,11111534,4477,Inconclusive,32879895.0,3091.0,1.9953,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
130,915,1,3,,11111533,4477,Active,32879895.0,3091.0,2.5119,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
131,915,1,3,,11111534,4477,Inconclusive,32879895.0,3091.0,1.9953,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
132,917,1,3,,11111533,4477,Active,120660324.0,7066.0,0.1,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
133,918,1,3,,11111533,4477,Inconclusive,120660324.0,7066.0,0.1,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
134,923,1,2,,11111533,4477,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
135,923,1,2,,11111534,4477,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
136,923,1,2,,26747596,4477,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
137,924,1,2,,11111533,4477,Inconclusive,120407068.0,7157.0,3.9811,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
138,924,1,2,,11111534,4477,Inconclusive,120407068.0,7157.0,1.2589,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
139,924,1,2,,26747596,4477,Inconclusive,120407068.0,7157.0,5.0119,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
140,925,1,2,,11111533,4477,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
141,925,1,2,,11111534,4477,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
142,926,1,2,,11111533,4477,Inconclusive,38016895.0,7253.0,1.0,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
143,926,1,2,,11111534,4477,Inconclusive,38016895.0,7253.0,0.5012,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
144,927,1,3,,11111533,4477,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
145,927,1,3,,11111534,4477,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
146,927,1,3,,26747596,4477,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
147,928,1,2,,11111533,4477,Inconclusive,21620132.0,4790.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
148,930,1,2,,26747596,4477,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
149,938,1,2,,11111533,4477,Active,38016895.0,7253.0,1.0,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
150,938,1,2,,11111534,4477,Active,38016895.0,7253.0,0.5012,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
151,940,1,2,,17405839,4477,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
152,940,1,2,,26612455,4477,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
153,943,1,2,,11111533,4477,Inconclusive,18249941.0,25229.0,0.0018,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
154,944,1,2,,11111533,4477,Inconclusive,18249941.0,25229.0,7.0795,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
155,945,1,4,,11111533,4477,Active,290753097.0,,2.5119,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
156,954,1,2,,11111533,4477,Inactive,33286420.0,5315.0,3.1623,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
157,957,1,2,,11111533,4477,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
158,958,1,2,,11111533,4477,Active,33286420.0,5315.0,3.1623,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
159,959,1,4,,11111533,4477,Inactive,290753097.0,,2.5119,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
160,992,1,3,,11111533,4477,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
161,995,1,2,,11111533,4477,Inactive,66932916.0,5594.0,0.5012,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
162,995,1,2,,11111534,4477,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
163,995,1,2,,26747596,4477,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
164,997,1,2,,11111533,4477,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
165,998,1,2,,11111533,4477,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
166,1030,2,1,,11111534,4477,Inconclusive,30582681.0,216.0,3.5481,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
167,1030,2,1,,26747596,4477,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
168,1030,2,1,,50106712,4477,Inconclusive,30582681.0,216.0,28.1838,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
169,1332,1,1,,49698803,4477,Active,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
170,1379,1,2,,11111534,4477,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
171,1379,1,2,,26747596,4477,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
172,1379,1,2,,50106712,4477,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
173,1422,1,1,,17405839,4477,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
174,1422,1,1,,26612455,4477,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
175,1452,1,1,,11111533,4477,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
176,1452,1,1,,11111534,4477,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
177,1452,1,1,,26747596,4477,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
178,1454,1,1,,11111534,4477,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
179,1454,1,1,,26747596,4477,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
180,1454,1,1,,50106712,4477,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
181,1457,1,1,,11111534,4477,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
182,1457,1,1,,26747596,4477,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
183,1457,1,1,,50106712,4477,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
184,1458,1,1,,11111534,4477,Active,10937869.0,6607.0,0.1259,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
185,1458,1,1,,26747596,4477,Active,10937869.0,6607.0,25.1189,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
186,1458,1,1,,50106712,4477,Inactive,10937869.0,6607.0,7.0795,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
187,1459,1,1,,50106712,4477,Inconclusive,27436948.0,4000.0,1.5849,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
188,1460,1,3,,26747596,4477,Active,92096784.0,4137.0,7.0795,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
189,1460,1,3,,50106712,4477,Inconclusive,92096784.0,4137.0,3.1623,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
190,1461,1,2,,50106712,4477,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
191,1463,1,1,,26747596,4477,Inconclusive,,,15.8489,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
192,1463,1,1,,50106712,4477,Inconclusive,,,3.5481,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
193,1467,1,3,,11111534,4477,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
194,1467,1,3,,26747596,4477,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
195,1467,1,3,,50106712,4477,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
196,1468,1,1,,26747596,4477,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
197,1468,1,1,,50106712,4477,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
198,1469,1,1,,11111534,4477,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
199,1469,1,1,,26747596,4477,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
200,1469,1,1,,26753613,4477,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
201,1469,1,1,,50106712,4477,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
202,1471,2,1,,11111533,4477,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
203,1471,2,1,,11111534,4477,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
204,1471,2,1,,26753613,4477,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
205,1476,2,1,,11111534,4477,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
206,1476,2,1,,26747596,4477,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
207,1476,2,1,,50106712,4477,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
208,1477,1,1,,11111534,4477,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
209,1477,1,1,,50106712,4477,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
210,1478,2,1,,11111534,4477,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
211,1478,2,1,,26747596,4477,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
212,1478,2,1,,50106712,4477,Active,281307097.0,,5.6234,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
213,1479,1,2,,11111534,4477,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
214,1479,1,2,,26747596,4477,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
215,1479,1,2,,26753613,4477,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
216,1479,1,2,,50106712,4477,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
217,1487,1,1,,11111534,4477,Inconclusive,27436948.0,4000.0,0.8913,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
218,1487,1,1,,26747596,4477,Inconclusive,27436948.0,4000.0,6.3096,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
219,1487,1,1,,26753613,4477,Inconclusive,27436948.0,4000.0,1.7783,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
220,1487,1,1,,50106712,4477,Inconclusive,27436948.0,4000.0,0.0251,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
221,1490,2,1,,11111534,4477,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
222,1490,2,1,,26747596,4477,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
223,1490,2,1,,26753613,4477,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
224,1519,1,3,,11111534,4477,Inconclusive,,,7.0795,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
225,1519,1,3,,26747596,4477,Inconclusive,,,3.1623,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
226,1519,1,3,,50106712,4477,Inconclusive,,,14.1254,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
227,1580,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
228,1581,1,1,,8149966,4477,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
229,1582,1,1,,8149966,4477,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
230,1583,1,1,,8149966,4477,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
231,1584,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
232,1585,1,1,,8149966,4477,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
233,1586,1,1,,8149966,4477,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
234,1587,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
235,1588,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
236,1589,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
237,1590,1,1,,8149966,4477,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
238,1593,1,1,,8149966,4477,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
239,1594,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
240,1595,1,1,,8149966,4477,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
241,1596,1,1,,8149966,4477,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
242,1597,1,1,,8149966,4477,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
243,1598,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
244,1599,1,1,,8149966,4477,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
245,1600,1,1,,8149966,4477,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
246,1601,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
247,1602,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
248,1603,1,1,,8149966,4477,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
249,1604,1,1,,8149966,4477,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
250,1605,1,1,,8149966,4477,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
251,1606,1,1,,8149966,4477,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
252,1607,1,1,,8149966,4477,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
253,1608,1,1,,8149966,4477,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
254,1609,1,1,,8149966,4477,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
255,1610,1,1,,8149966,4477,Active,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
256,1612,1,1,,8149966,4477,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
257,1613,1,1,,8149966,4477,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
258,1614,1,1,,8149966,4477,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
259,1616,1,1,,8149966,4477,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
260,1688,1,1,,26753613,4477,Inconclusive,90903231.0,3064.0,0.7943,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
261,1705,1,2,,50106712,4477,Inactive,6980812.0,,,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
262,1707,1,3,,50106712,4477,Active,,,3.9811,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
263,1708,1,3,,50106712,4477,Inconclusive,405898.0,,11.2202,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
264,1733,1,1,,11111534,4477,Active,,,0.7943,Potency,Counterscreen Assay for Enhancers of SMN2 Splice Variant Expression: Interaction with Luciferase Reporter,Confirmatory,,
265,1739,1,1,,11111534,4477,Active,4507091.0,6606.0,,,Counterscreen Assay for Enhancers of SMN2 Splice Variant Expression: Modulation of SMN1 Expression,Confirmatory,,
266,1740,1,1,,11111534,4477,Unspecified,10937869.0,6607.0,,Potency,Confirmation Concentration-Response Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
267,1766,1,1,,11111534,4477,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
268,1766,1,1,,11111534,4477,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
269,1766,1,1,,26747596,4477,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
270,1766,1,1,,26747596,4477,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
271,1766,1,1,,26753613,4477,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
272,1766,1,1,,26753613,4477,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
273,1766,1,1,,50106712,4477,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
274,1766,1,1,,50106712,4477,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
275,1768,1,1,,11111534,4477,Inconclusive,18860839.0,4221.0,3.5481,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
276,1768,1,1,,11111534,4477,Inconclusive,56550039.0,4297.0,3.5481,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
277,1768,1,1,,26747596,4477,Inconclusive,18860839.0,4221.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
278,1768,1,1,,26747596,4477,Inconclusive,56550039.0,4297.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
279,1768,1,1,,26753613,4477,Inconclusive,18860839.0,4221.0,7.9433,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
280,1768,1,1,,26753613,4477,Inconclusive,56550039.0,4297.0,7.9433,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
281,1768,1,1,,50106712,4477,Inconclusive,18860839.0,4221.0,2.8184,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
282,1768,1,1,,50106712,4477,Inconclusive,56550039.0,4297.0,2.8184,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
283,1815,1,1,,50106712,4477,Active,,,1.0,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
284,1816,1,1,,50106712,4477,Active,,,0.7079,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
285,1828,2,1,,50106712,4477,Active,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
286,1850,2,1,,56463356,4477,Active,,,122.84,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
287,1851,1,2,,11111533,4477,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
288,1851,1,2,,11111534,4477,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
289,1851,1,2,1.0,11111533,4477,Inactive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
290,1851,1,2,1.0,11111534,4477,Inconclusive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
291,1851,1,2,2.0,11111533,4477,Active,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
292,1851,1,2,2.0,11111534,4477,Inactive,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
293,1851,1,2,3.0,11111533,4477,Inconclusive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
294,1851,1,2,3.0,11111534,4477,Active,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
295,1851,1,2,4.0,11111533,4477,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
296,1851,1,2,4.0,11111534,4477,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
297,1851,1,2,5.0,11111533,4477,Active,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
298,1851,1,2,5.0,11111534,4477,Active,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
299,1863,2,1,,56463356,4477,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
300,1865,1,1,,11111534,4477,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
301,1865,1,1,,26747596,4477,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
302,1865,1,1,,50106712,4477,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
303,1876,1,1,,50106712,4477,Active,,,0.7943,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
304,1877,1,1,,50106712,4477,Active,,,1.0,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
305,1882,1,1,,50106712,4477,Active,,,1.4125,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
306,1883,1,1,,50106712,4477,Active,,,0.7943,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
307,1886,1,1,,50106712,4477,Active,,,0.7943,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
308,1899,1,3,,56463356,4477,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
309,1903,2,3,,56463356,4477,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
310,1906,1,3,,56463356,4477,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
311,1947,1,2,,56463356,4477,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
312,1948,1,1,,11111534,4477,Inactive,,,1.0,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
313,1948,1,1,,26747596,4477,Inactive,,,10.0,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
314,1948,1,1,,50106712,4477,Inactive,,,2.5119,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
315,1950,1,3,,56463356,4477,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
316,1962,1,2,,56463356,4477,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
317,1967,1,1,,85231153,4477,Inconclusive,4505907.0,5376.0,0.3793,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
318,1974,1,2,,56463356,4477,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
319,1985,2,1,,56463356,4477,Active,,,76.045,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen,Confirmatory,,
320,1987,1,2,,56463356,4477,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
321,2016,1,3,,56463356,4477,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
322,2023,1,3,,56463356,4477,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
323,2025,1,3,,56463356,4477,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
324,2029,1,3,,56463356,4477,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
325,2052,2,1,,56463356,4477,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
326,2057,1,2,,56463356,4477,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
327,2066,1,4,,56463356,4477,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
328,2101,1,1,,11111534,4477,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
329,2101,1,1,,26747596,4477,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
330,2101,1,1,,50106712,4477,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
331,2101,1,1,,56463356,4477,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
332,2107,1,1,,11111534,4477,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
333,2107,1,1,,26747596,4477,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
334,2107,1,1,,50106712,4477,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
335,2112,1,1,,11111534,4477,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
336,2112,1,1,,26747596,4477,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
337,2112,1,1,,50106712,4477,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
338,2129,1,2,,56463356,4477,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
339,2130,1,3,,56463356,4477,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
340,2147,1,1,,11111534,4477,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
341,2147,1,1,,26747596,4477,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
342,2147,1,1,,50106712,4477,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
343,2174,1,3,,56463356,4477,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
344,2177,1,3,,56463356,4477,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
345,2234,1,2,,56463356,4477,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
346,2235,1,2,,56463356,4477,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
347,2240,1,1,,85788811,4477,Active,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
348,2241,1,1,,85788811,4477,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
349,2252,1,1,,56463356,4477,Active,,,1.93,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen,Confirmatory,,
350,2275,1,1,,85788811,4477,Active,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
351,2280,2,3,,56463356,4477,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
352,2300,1,3,,56463356,4477,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
353,2313,1,1,,85788811,4477,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
354,2322,1,1,,85788811,4477,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
355,2323,1,1,,50106712,4477,Inconclusive,254220970.0,,28.1838,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
356,2326,1,1,,50106712,4477,Inactive,194352380.0,,3.5481,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
357,2330,1,1,,85788811,4477,Active,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
358,2353,1,3,,50106712,4477,Inactive,282403581.0,,,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
359,2364,1,2,,50106712,4477,Inconclusive,4557365.0,641.0,19.9526,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
360,2380,1,2,,56463356,4477,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
361,2384,1,1,,56463356,4477,Active,,,19.68,IC50,A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
362,2391,1,1,,56463356,4477,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
363,2435,1,2,,56463356,4477,Active,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
364,2445,1,2,,56463356,4477,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
365,2451,1,2,,11111534,4477,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
366,2451,1,2,,26747596,4477,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
367,2451,1,2,,50106712,4477,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
368,2462,1,1,,56463356,4477,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
369,2462,1,1,,56463356,4477,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
370,2472,1,2,,11111534,4477,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
371,2472,1,2,,26747596,4477,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
372,2517,2,1,,11111534,4477,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
373,2517,2,1,,26747596,4477,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
374,2517,2,1,,50106712,4477,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
375,2517,2,1,,56463356,4477,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
376,2520,1,4,,56463356,4477,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
377,2521,1,3,,56463356,4477,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
378,2524,1,2,,56463356,4477,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
379,2528,1,2,,11111534,4477,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
380,2528,1,2,,26747596,4477,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
381,2528,1,2,,26753613,4477,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
382,2528,1,2,,50106712,4477,Inconclusive,4557365.0,641.0,19.9526,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
383,2540,1,2,,56463356,4477,Active,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
384,2544,1,2,,56463356,4477,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
385,2546,1,1,,11111534,4477,Active,188536040.0,19885.0,31.6228,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
386,2546,1,1,,26747596,4477,Active,188536040.0,19885.0,3.9811,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
387,2546,1,1,,26753613,4477,Active,188536040.0,19885.0,1.2589,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
388,2549,1,1,,11111534,4477,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
389,2549,1,1,,26747596,4477,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
390,2549,1,1,,50106712,4477,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
391,2551,1,1,,11111534,4477,Active,188536040.0,19885.0,0.5623,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
392,2551,1,1,,26747596,4477,Active,188536040.0,19885.0,6.3096,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
393,2551,1,1,,26753613,4477,Active,188536040.0,19885.0,1.2589,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
394,2557,1,3,,56463356,4477,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
395,2599,1,2,,56463356,4477,Active,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
396,2606,1,2,,56463356,4477,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
397,2629,1,1,,56463356,4477,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
398,2650,2,1,,56463356,4477,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
399,2660,1,1,,90341111,4477,Inactive,4826730.0,2475.0,,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
400,2661,1,1,,56463356,4477,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
401,2662,2,1,,85231153,4477,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
402,2666,1,1,,90341111,4477,Inactive,4826730.0,2475.0,,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
403,2667,1,1,,90341111,4477,Active,4826730.0,2475.0,2.0749,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
404,2668,1,1,,90341111,4477,Active,4826730.0,2475.0,1.1668,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
405,2675,1,1,,50106712,4477,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
406,2676,1,2,,56463356,4477,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
407,2685,1,1,,56463356,4477,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
408,2690,1,2,,56463356,4477,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
409,2716,1,1,,56463356,4477,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
410,2717,1,2,,56463356,4477,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
411,2718,1,1,,56463356,4477,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
412,2732,1,1,,17405839,4477,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
413,2751,2,2,,56463356,4477,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
414,2774,1,3,,92304181,4477,Inactive,,,,,LOPAC Circadian Assay,Screening,,
415,2796,1,4,,56463356,4477,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
416,2797,1,2,,56463356,4477,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
417,2805,2,2,,56463356,4477,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
418,2806,2,2,,56463356,4477,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
419,2825,1,2,,56463356,4477,Active,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
420,242440,8,2,,103516894,4477,Unspecified,,,10.0,IC50,Concentration required to inhibit SARS-CoV 3CL protease catalyzed cleavage of fluorogenic peptide Dabcyl-KTSAVLQSGFRKME-Edans by 50%,Confirmatory,15974598.0,
421,285159,8,1,,103516894,4477,Unspecified,,,,,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed by relative light units after 7 days,Other,17210775.0,
422,285160,8,1,,103516894,4477,Unspecified,,,,,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in aerobic condition assessed as bacterial density after 7 days,Other,17210775.0,
423,285161,8,1,,103516894,4477,Unspecified,,,,,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as relative light unit after 11 days by LORA assay,Other,17210775.0,
424,285162,8,1,,103516894,4477,Active,,,,,Antimicrobial activity against non replicating persistence Mycobacterium tuberculosis H37Rv in anaerobic condition assessed as bacterial density after 10 days,Other,17210775.0,
425,297145,3,4,,103516894,4477,Unspecified,,,,,Inhibition of SARS coronavirus-induced cytopathogenicity in Vero E6 cells at 20 uM,Other,17663539.0,
426,297146,3,4,,103516894,4477,Unspecified,,,,,Inhibition of SARS coronavirus-induced cytopathogenicity in Vero E6 cells at 10 uM,Other,17663539.0,
427,297147,5,4,,103516894,4477,Unspecified,,,,,Inhibition of SARS virus-induced cytopathogenicity in Vero E6 cells at 3.3 uM,Other,17663539.0,
428,297148,5,4,,103516894,4477,Unspecified,,,,,Inhibition of SARS virus-induced cytopathogenicity in Vero E6 cells at 1 uM,Other,17663539.0,
429,297149,6,2,,103516894,4477,Active,,,0.1,EC50,Antiviral activity against SARS coronavirus in Vero E6 cells assessed as inhibition of viral replication by ELISA,Confirmatory,17663539.0,
430,297150,6,2,,103516894,4477,Active,,,22.1,CC50,Cytotoxicity against Vero E6 cells by MTT assay,Confirmatory,17663539.0,
431,297151,3,4,,103516894,4477,Unspecified,,,,,"Selectivity index, Ratio of CC50 for Vero E6 cells to EC50 for SARS coronavirus",Other,17663539.0,
432,297152,6,2,,103516894,4477,Active,,,40.0,IC50,Inhibition of SARS coronavirus 3CL protease,Confirmatory,17663539.0,
433,399284,3,4,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Lymnaea acuminata within 24 hrs,Other,6491683.0,
434,423372,6,2,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Biomphalaria pfeifferi,Other,19239238.0,
435,423373,6,2,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Biomphalaria alexandrina,Other,19239238.0,
436,423374,6,2,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Oncomelania hupensis,Other,19239238.0,
437,429432,9,2,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Biomphalaria glabrata after 24 hrs,Other,19376614.0,
438,434955,1,2,,56463356,4477,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
439,434959,1,1,,85788811,4477,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
440,434962,1,2,,56463356,4477,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
441,434963,1,1,,56463356,4477,Inactive,32307152.0,5021.0,,,Fluorescence-based cell-based high throughput confirmation assay for agonists of the Oxytocin Receptor (OXTR),Screening,,
442,434973,1,3,,56463356,4477,Active,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
443,434989,1,1,,56463356,4477,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
444,434991,1,1,,56463356,4477,Inactive,4502331.0,552.0,,,"Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based cell-based high throughput screening assay to identify agonists of the vasopressin 1 receptor (V1R), in triplicate",Screening,,
445,435003,1,3,,56463356,4477,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
446,435005,1,1,,56463356,4477,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
447,435006,1,2,,56463356,4477,Active,219518789.0,114548.0,,,Single concentration confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay,Screening,,
448,435022,2,2,,56463356,4477,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
449,435030,1,2,,56463356,4477,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
450,435030,1,2,,56463356,4477,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
451,449728,1,2,,56463356,4477,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
452,449746,1,2,,56463356,4477,Inactive,,,,,Single concentration confirmation of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
453,449756,1,1,,56463356,4477,Active,,,0.9105,AC50_uM,Luminescence Cell-Based Dose Retest to Confirm Inhibitors of  Beta Cell Apoptosis,Confirmatory,,
454,449762,1,2,,56463356,4477,Inconclusive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
455,449763,1,3,,56463356,4477,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
456,450327,3,4,,103516894,4477,Active,,,,,Cytoprotective activity against anthrax toxin lethal factor/protective antigen-induced cell death in mouse RAW264.7 cells assessed as cell viability at 10 uM by MTT reduction assay,Other,19540764.0,
457,450330,3,4,,103516894,4477,Active,,,,,Cytoprotective activity against anthrax fusion toxin FP59-induced cell death in CHO cells assessed as cell viability by MTT reduction assay,Other,19540764.0,
458,450331,3,4,,103516894,4477,Unspecified,,,,,Cytoprotective activity against diphtheria toxin-induced cell death in CHO cells assessed as cell viability at 5 uM by MTT reduction assay,Other,19540764.0,
459,450333,3,10,,103516894,4477,Active,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax protective antigen heptamer pre-pore to pore conversion in CMG2-expressing CHO cells,Other,19540764.0,
460,450334,3,10,,103516894,4477,Active,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax protective antigen heptamer pre-pore to pore conversion in TEM8-expressing CHO cell,Other,19540764.0,
461,450335,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax protective antigen binding to CMG2 expressing CHO cells,Other,19540764.0,
462,450336,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax protective antigen binding to TEM8-expressing CHO cells,Other,19540764.0,
463,450337,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax proteolytic protective antigen processing in CMG2 expressing CHO cells,Other,19540764.0,
464,450338,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax proteolytic protective antigen processing in TEM2 expressing CHO cells,Other,19540764.0,
465,450339,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of heptamerization of Bacillus anthracis anthrax protective antigen in CMG2 expressing CHO cells,Other,19540764.0,
466,450340,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of heptamerization of Bacillus anthracis anthrax protective antigen in TEM2 expressing CHO cells,Other,19540764.0,
467,450341,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax protective antigen-dependent lethal factor binding in CMG2 expressing CHO cells,Other,19540764.0,
468,450342,3,10,,103516894,4477,Inactive,17380160.0,3361714.0,,,Inhibition of Bacillus anthracis anthrax protective antigen-dependent lethal factor binding in TEM2 expressing CHO cells,Other,19540764.0,
469,450343,5,2,,103516894,4477,Active,,,40.0,IC50,Inhibition of SARS Co-V 3CL protease,Confirmatory,19540764.0,
470,463079,1,2,,56463356,4477,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
471,463082,1,1,,56463356,4477,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
472,463096,1,1,,50106712,4477,Active,,,5.0119,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
473,463097,1,1,,50106712,4477,Active,7705682.0,51053.0,0.3162,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
474,463104,1,2,,56463356,4477,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
475,463106,1,2,,90341111,4477,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
476,463141,1,2,,56463356,4477,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
477,463189,1,1,,53777972,4477,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
478,463190,1,2,,56463356,4477,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
479,463195,1,2,,56463356,4477,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
480,463206,1,1,,56463356,4477,Inactive,,,260.0,AC50_uM,Luminescence Cell-Based Counter Screen to Identify Inhibitors of Cytokine Induced Apoptosis,Confirmatory,,
481,463210,1,2,,56463356,4477,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
482,463212,1,1,,56463356,4477,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
483,463229,1,1,,56463356,4477,Active,,,1.04,AC50_uM,ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick,Confirmatory,,
484,463254,1,1,,56463356,4477,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
485,478745,3,3,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Biomphalaria alexandrina assessed as mortality at 1 ppm after 24 hrs,Other,20153090.0,
486,478746,3,3,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Biomphalaria alexandrina assessed as mortality at 5 ppm after 24 hrs,Other,20153090.0,
487,478747,3,3,,103516894,4477,Unspecified,,,,,Molluscicidal activity against Biomphalaria alexandrina assessed as mortality at 10 ppm after 24 hrs,Other,20153090.0,
488,485270,1,1,,56463356,4477,Active,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
489,485272,1,1,,56463356,4477,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
490,485273,2,1,,56463356,4477,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
491,485275,1,3,,56463356,4477,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
492,485281,1,1,,11111534,4477,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
493,485290,1,1,,11111534,4477,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
494,485290,1,1,,26747596,4477,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
495,485290,1,1,,26753613,4477,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
496,485290,1,1,,50106712,4477,Inactive,20150581.0,,0.0398,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
497,485294,1,1,,56463356,4477,Inconclusive,119389684.0,,5.6234,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
498,485295,1,2,,90341111,4477,Inactive,30027657.0,,,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
499,485297,1,1,,56463356,4477,Inconclusive,4759012.0,9367.0,0.0794,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
500,485297,1,1,,90341111,4477,Active,4759012.0,9367.0,0.1,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
501,485298,1,1,,56463356,4477,Inactive,,,1.4125,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
502,485298,1,1,,90341111,4477,Inactive,,,4.1095,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
503,485313,1,2,,56463356,4477,Active,255652944.0,4864.0,0.0398,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
504,485313,1,2,,90341111,4477,Active,255652944.0,4864.0,0.0651,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
505,485314,1,1,,50106712,4477,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
506,485317,1,2,,56463356,4477,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
507,485341,1,1,,56463356,4477,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
508,485342,1,2,,90341111,4477,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
509,485344,1,1,,56463356,4477,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
510,485345,1,2,,90341111,4477,Inconclusive,,,0.3663,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
511,485346,1,1,,56463356,4477,Active,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
512,485346,1,1,,56463356,4477,Active,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
513,485347,1,2,,56463356,4477,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
514,485349,1,1,,56463356,4477,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
515,485350,1,2,,92125105,4477,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
516,485358,1,1,,56463356,4477,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
517,485360,1,1,,56463356,4477,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
518,485364,1,1,,56463356,4477,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
519,485366,1,2,,90341111,4477,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
520,485367,1,2,,56463356,4477,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
521,485368,1,2,,90341111,4477,Inactive,72386991.0,3656265.0,,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
522,488745,1,4,,85231153,4477,Inconclusive,,,3.2944,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
523,488752,1,4,,85231153,4477,Inconclusive,,,1.3115,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
524,488772,1,1,,90341111,4477,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
525,488773,1,2,,90341111,4477,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
526,488784,1,2,,56463356,4477,Active,219518789.0,114548.0,,,Single concentration confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen,Screening,,
527,488794,1,2,,56463356,4477,Active,219518789.0,114548.0,,,Single concentration confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay - retest,Screening,,
528,488816,1,1,,90341111,4477,Inactive,4758356.0,2237.0,,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
529,488837,1,1,,56463356,4477,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
530,488837,1,1,,90341111,4477,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
531,488839,1,1,,56463356,4477,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
532,488839,1,1,,56463356,4477,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
533,488847,1,3,,56463356,4477,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
534,488862,1,1,,56463356,4477,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
535,488890,1,2,,56463356,4477,Inconclusive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
536,488895,1,2,,56463356,4477,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
537,488896,1,1,,56463356,4477,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
538,488899,1,1,,56463356,4477,Active,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
539,488949,1,2,,85231153,4477,Inconclusive,41055989.0,54737.0,79.4328,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
540,488949,1,2,,90341111,4477,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
541,488953,1,1,,90341111,4477,Inactive,187960037.0,10951.0,,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
542,488965,1,2,,56463356,4477,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
543,488966,1,1,,56463356,4477,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
544,488975,1,2,,56463356,4477,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
545,488977,1,2,,56463356,4477,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
546,488978,1,1,,90341111,4477,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
547,488979,1,1,,50106712,4477,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
548,488980,1,1,,85231153,4477,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
549,488981,1,1,,90341111,4477,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
550,488982,1,1,,90341111,4477,Inactive,4503383.0,1812.0,0.2909,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
551,488983,1,1,,90341111,4477,Inconclusive,4503383.0,1812.0,0.3981,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
552,489028,1,2,,56463356,4477,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
553,489028,1,2,,56463356,4477,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
554,489030,2,1,,56463356,4477,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
555,489031,2,1,,56463356,4477,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
556,492947,1,1,,56463356,4477,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
557,492951,1,2,,99380769,4477,Active,4503951.0,2645.0,,,Human Glck Counter Screen Assay,Confirmatory,,
558,492953,1,1,,56463356,4477,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
559,492956,1,1,,56463356,4477,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
560,492967,1,2,,92125105,4477,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
561,492967,1,2,,99301797,4477,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
562,492972,1,1,,56463356,4477,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
563,493005,1,1,,56463356,4477,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
564,493008,1,1,,56463356,4477,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
565,493008,1,1,,56463356,4477,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
566,493008,1,1,,56463356,4477,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
567,493008,1,1,,56463356,4477,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
568,493011,1,1,,56463356,4477,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
569,493012,1,1,,56463356,4477,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
570,493014,1,1,,56463356,4477,Inconclusive,,,0.3663,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
571,493033,1,2,,92125105,4477,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
572,493036,1,2,,56463356,4477,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
573,493056,1,1,,56463356,4477,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
574,493084,1,1,,56463356,4477,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
575,493087,1,1,,56463356,4477,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
576,493091,1,1,,56463356,4477,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
577,493098,1,1,,56463356,4477,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
578,493106,1,1,,90341111,4477,Inactive,116283940.0,79915.0,,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
579,493107,1,1,,90341111,4477,Inconclusive,116283940.0,79915.0,1.4575,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
580,493127,1,1,,50106712,4477,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
581,493131,1,1,,56463356,4477,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
582,493140,1,1,,103913900,4477,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
583,493153,1,1,,90341111,4477,Inconclusive,,4780.0,2.9093,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
584,493153,1,1,,90341111,4477,Inconclusive,224028257.0,4780.0,2.9093,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
585,493160,1,1,,56463356,4477,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
586,493162,1,2,,99301797,4477,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
587,493164,1,2,,90341111,4477,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
588,493164,1,2,,90341111,4477,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
589,493164,1,2,,90341111,4477,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
590,493187,1,2,,56463356,4477,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
591,493189,1,1,,50106712,4477,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
592,493244,1,1,,56463356,4477,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
593,493244,1,1,,56463356,4477,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
594,493244,1,1,,56463356,4477,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
595,493244,1,1,,56463356,4477,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
596,503299,4,2,,103516894,4477,Active,,,0.4,IC50,Antiproliferative activity against human PC3 cells after 120 hrs by MTT assay,Confirmatory,16680159.0,
597,503300,4,2,,103516894,4477,Active,,,0.4,IC50,Antiproliferative activity against human A549 cells after 120 hrs by MTT assay,Confirmatory,16680159.0,
598,503301,4,2,,103516894,4477,Active,,,1.1,IC50,Antiproliferative activity against human MIAPaCa2cells after 120 hrs by MTT assay,Confirmatory,16680159.0,
599,503302,4,2,,103516894,4477,Active,,,0.7,IC50,Antiproliferative activity against human LoVo cells after 120 hrs by MTT assay,Confirmatory,16680159.0,
600,503303,4,3,,103516894,4477,Active,,,0.4,IC50,Antiproliferative activity against human U87MG cells after 120 hrs by MTT assay,Confirmatory,16680159.0,
601,503318,2,5,,103516894,4477,Unspecified,,,,,Antiproliferative activity against human PC3 cells at 1 uM after 120 hrs by MTT assay relative to DMSO,Other,16680159.0,
602,503323,3,4,,103516894,4477,Active,,,,,Inhibition of mitochondrial membrane potential in human PC3 cells after 1 hr,Other,16680159.0,
603,503324,3,4,,103516894,4477,Active,,,,,Inhibition of mitochondrial membrane potential in human HEK293 cells after 1 hr,Other,16680159.0,
604,504326,1,2,,56463356,4477,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
605,504326,1,2,,56463356,4477,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
606,504327,1,1,,11111534,4477,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
607,504327,1,1,,56463356,4477,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
608,504327,1,1,,90341111,4477,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
609,504329,1,1,,56463356,4477,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
610,504332,1,1,,11111534,4477,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
611,504332,1,1,,50106712,4477,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
612,504332,1,1,,56463356,4477,Inconclusive,168985070.0,,3.1623,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
613,504332,1,1,,90341111,4477,Active,168985070.0,,7.9433,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
614,504333,1,1,,56463356,4477,Inactive,6683500.0,29994.0,,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
615,504339,1,1,,56463356,4477,Inconclusive,162330054.0,,70.7946,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
616,504357,1,1,,56463356,4477,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
617,504357,1,1,,56463356,4477,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
618,504364,1,1,,85231153,4477,Inconclusive,7705682.0,51053.0,2.0596,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
619,504406,1,1,,56463356,4477,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
620,504411,1,1,,56463356,4477,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
621,504414,1,1,,56463356,4477,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
622,504414,1,1,,56463356,4477,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
623,504423,1,1,,56463356,4477,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
624,504441,1,1,,56463356,4477,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
625,504444,1,1,,56463356,4477,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
626,504454,1,3,,56463356,4477,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
627,504462,1,1,,56463356,4477,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
628,504466,1,1,,56463356,4477,Inconclusive,116283940.0,79915.0,0.057999999999999996,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
629,504467,1,1,,56463356,4477,Inconclusive,116283940.0,79915.0,1.122,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
630,504490,1,2,,56463356,4477,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
631,504523,1,1,,56463356,4477,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
632,504523,1,1,,56463356,4477,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
633,504536,1,1,,90341111,4477,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
634,504547,1,1,,90341111,4477,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
635,504548,1,2,,90341111,4477,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
636,504558,1,1,,56463356,4477,Active,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
637,504577,2,2,,56463356,4477,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
638,504582,2,1,,56463356,4477,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
639,504601,1,1,,56463356,4477,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format - Set 2,Screening,,
640,504601,1,1,,56463356,4477,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format - Set 2,Screening,,
641,504607,1,1,,56463356,4477,Active,,,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay,Screening,,
642,504621,1,1,,56463356,4477,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
643,504634,1,1,,56463356,4477,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
644,504648,1,1,,56463356,4477,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
645,504651,1,1,,56463356,4477,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
646,504652,1,1,,56463356,4477,Active,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
647,504660,1,1,,56463356,4477,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
648,504668,1,1,,56463356,4477,Active,728984.0,672.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
649,504668,1,1,,56463356,4477,Active,116241265.0,580.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
650,504690,1,3,,56463356,4477,Active,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
651,504692,2,2,,56463356,4477,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
652,504700,1,1,,56463356,4477,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
653,504700,1,1,,56463356,4477,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
654,504706,1,1,,56463356,4477,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
655,504707,1,1,,56463356,4477,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
656,504707,1,1,,56463356,4477,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
657,504720,1,1,,56463356,4477,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
658,504734,1,1,,56463356,4477,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
659,504749,1,3,,26753613,4477,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
660,504749,1,3,,104171199,4477,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
661,504749,1,3,1.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
662,504749,1,3,2.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
663,504749,1,3,3.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
664,504749,1,3,4.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
665,504749,1,3,5.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
666,504749,1,3,6.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
667,504749,1,3,7.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
668,504749,1,3,8.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
669,504749,1,3,9.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
670,504749,1,3,10.0,26753613,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
671,504749,1,3,11.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
672,504749,1,3,12.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
673,504749,1,3,13.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
674,504749,1,3,14.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
675,504749,1,3,15.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
676,504749,1,3,16.0,26753613,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
677,504749,1,3,17.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
678,504749,1,3,18.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
679,504749,1,3,19.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
680,504749,1,3,20.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
681,504749,1,3,21.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
682,504749,1,3,22.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
683,504749,1,3,23.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
684,504749,1,3,24.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
685,504749,1,3,25.0,26753613,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
686,504749,1,3,26.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
687,504749,1,3,27.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
688,504749,1,3,28.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
689,504749,1,3,29.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
690,504749,1,3,30.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
691,504749,1,3,31.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
692,504749,1,3,32.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
693,504749,1,3,33.0,104171199,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
694,504749,1,3,34.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
695,504749,1,3,35.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
696,504749,1,3,36.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
697,504749,1,3,37.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
698,504749,1,3,38.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
699,504749,1,3,39.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
700,504749,1,3,40.0,26753613,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
701,504749,1,3,41.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
702,504749,1,3,42.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
703,504749,1,3,43.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
704,504749,1,3,44.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
705,504749,1,3,45.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
706,504749,1,3,46.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
707,504749,1,3,47.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
708,504749,1,3,48.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
709,504749,1,3,49.0,26753613,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
710,504749,1,3,50.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
711,504749,1,3,51.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
712,504749,1,3,52.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
713,504749,1,3,53.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
714,504749,1,3,54.0,26753613,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
715,504749,1,3,55.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
716,504749,1,3,56.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
717,504749,1,3,57.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
718,504749,1,3,58.0,26753613,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
719,504749,1,3,59.0,104171199,4477,Inconclusive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
720,504749,1,3,60.0,104171199,4477,Active,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
721,504749,1,3,61.0,26753613,4477,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
722,504753,1,2,,56463356,4477,Active,12381848.0,,,,Single concentration confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
723,504765,1,1,,56463356,4477,Active,12381848.0,,13.7,IC50_Mean,Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Confirmatory,,
724,504766,2,1,,56463356,4477,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
725,504775,1,1,,56463356,4477,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
726,504792,1,2,,56463356,4477,Inactive,108773793.0,2539.0,80.0,IC50_Mean,Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase,Confirmatory,,
727,504803,1,1,,56463356,4477,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
728,504810,1,2,,56463356,4477,Active,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
729,504810,1,2,,90341111,4477,Active,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
730,504812,1,2,,56463356,4477,Active,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
731,504812,1,2,,90341111,4477,Active,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
732,504821,1,1,,85231153,4477,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
733,504832,1,1,,56463356,4477,Inconclusive,,,0.9285,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
734,504832,1,1,,104171199,4477,Inconclusive,,,3.0131,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
735,504834,1,1,,56463356,4477,Inconclusive,,,0.2617,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
736,504834,1,1,,104171199,4477,Inconclusive,,,0.4256,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
737,504836,1,2,,90341111,4477,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
738,504842,1,1,,56463356,4477,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
739,504845,1,1,,56463356,4477,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
740,504845,1,1,,90341111,4477,Inconclusive,86301163.0,5999.0,16.8336,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
741,504847,1,1,,11111534,4477,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
742,504847,1,1,,56463356,4477,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
743,504847,1,1,,90341111,4477,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
744,504847,1,1,,104171199,4477,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
745,504862,1,1,,56463356,4477,Inactive,,,,,uHTS Identification of Diaphorase Inhibitors and Chemical Oxidizers: Counter Screen for the uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay in the presence of 10 uM NADPH,Screening,,
746,504863,1,1,,56463356,4477,Inactive,,,,,uHTS Identification of Diaphorase Inhibitors and Chemical Oxidizers: Counter Screen for the uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay in the presence of 30 uM NADPH,Screening,,
747,504865,1,1,,11111534,4477,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
748,504865,1,1,,90341111,4477,Inconclusive,118600387.0,7398.0,56.2341,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
749,504865,1,1,,104171199,4477,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
750,504884,1,2,,56463356,4477,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
751,504891,1,1,,56463356,4477,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
752,504894,1,1,,56463356,4477,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
753,504937,1,2,,56463356,4477,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
754,521220,3,3,,103516894,4477,Active,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
755,524790,7,2,,103516894,4477,Active,,,0.0008900000000000001,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
756,524791,7,2,,103516894,4477,Active,,,0.0008900000000000001,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
757,524792,7,2,,103516894,4477,Active,,,0.001,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
758,524793,7,2,,103516894,4477,Active,,,0.00148,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
759,524794,7,1,,103516894,4477,Active,,,0.00074,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
760,524795,7,2,,103516894,4477,Active,,,0.0008900000000000001,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
761,524796,7,1,,103516894,4477,Active,,,0.00056,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
762,536125,1,4,,103516894,4477,Active,,,,,Molluscicidal activity against Biomphalaria alexandrina at 1 ppm after 24 hrs,Other,20801555.0,
763,536126,1,4,,103516894,4477,Active,,,,,Molluscicidal activity against Biomphalaria alexandrina at 5 ppm after 24 hrs,Other,20801555.0,
764,536127,1,4,,103516894,4477,Active,,,,,Molluscicidal activity against Biomphalaria alexandrina at 10 ppm after 24 hrs,Other,20801555.0,
765,540252,1,1,,56463356,4477,Inactive,12381848.0,,80.0,IC50_Mean,Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase,Confirmatory,,
766,540253,1,1,,56463356,4477,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
767,540253,1,1,,56463356,4477,Inactive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
768,540253,1,1,,56463356,4477,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
769,540256,1,2,,50106712,4477,Active,,,5.0119,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
770,540256,1,2,,90341111,4477,Active,,,1.2990000000000002,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
771,540263,1,1,,56463356,4477,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
772,540263,1,1,,56463356,4477,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
773,540267,1,1,,56463356,4477,Inconclusive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
774,540269,1,1,,56463356,4477,Inactive,12381848.0,,80.0,IC50_Mean,Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase,Confirmatory,,
775,540275,1,1,,56463356,4477,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
776,540276,1,2,,11111533,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
777,540276,1,2,,11111534,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
778,540276,1,2,,26747596,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
779,540276,1,2,,26753613,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
780,540276,1,2,,50100291,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
781,540276,1,2,,50106712,4477,Active,420597.0,,1.122,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
782,540276,1,2,,50106713,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
783,540276,1,2,,85231153,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
784,540276,1,2,,90341111,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
785,540276,1,2,,104171199,4477,Inconclusive,420597.0,,1.6353,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
786,540277,1,1,,56463356,4477,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
787,540295,1,1,,56463356,4477,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
788,540299,1,2,,92125105,4477,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
789,540303,1,1,,56463356,4477,Inconclusive,6679377.0,18792.0,3.5481,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
790,540303,1,1,,56463356,4477,Inconclusive,7242179.0,18793.0,3.5481,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
791,540303,1,1,,56463356,4477,Inconclusive,257471003.0,18815.0,3.5481,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
792,540308,1,1,,56463356,4477,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
793,540317,1,1,,56463356,4477,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
794,540336,1,1,,56463356,4477,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
795,540336,1,1,,56463356,4477,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
796,540364,1,2,,56463356,4477,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
797,562240,5,2,,103516894,4477,Active,,,6.85,IC50,Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry,Confirmatory,19786608.0,
798,562241,5,2,,103516894,4477,Active,,,3.31,IC50,Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry,Confirmatory,19786608.0,
799,562242,5,2,,103516894,4477,Active,,,4.73,IC50,Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by spectrophotometry,Confirmatory,19786608.0,
800,562243,5,2,,103516894,4477,Active,,,6.85,IC50,Antimycobacterial activity against Mycobacterium smegmatis grown in Luria-Bertani broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay,Confirmatory,19786608.0,
801,562244,5,2,,103516894,4477,Active,,,3.31,IC50,Antimycobacterial activity against Mycobacterium smegmatis grown in carbon-limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay,Confirmatory,19786608.0,
802,562245,5,2,,103516894,4477,Active,,,4.73,IC50,Antimycobacterial activity against Mycobacterium smegmatis grown in nitrogen -limited broth medium assessed as growth inhibition in mid-logarithmic phase by GFP-based fluorescence assay,Confirmatory,19786608.0,
803,572876,6,1,,103516894,4477,Active,,,,,Antibacterial activity against wild-type Mycobacterium bovis BCG by microplate Alamar Blue assay,Other,18625764.0,
804,572877,6,1,,103516894,4477,Active,,,,,Antibacterial activity against Mycobacterium bovis BCG harboring fgd gene by microplate Alamar Blue assay,Other,18625764.0,
805,572878,6,1,,103516894,4477,Active,,,,,Antibacterial activity against Mycobacterium bovis BCG harboring moaA gene by microplate Alamar Blue assay,Other,18625764.0,
806,572879,6,1,,103516894,4477,Active,,,,,Antibacterial activity against Mycobacterium bovis BCG harboring fbiC gene by microplate Alamar Blue assay,Other,18625764.0,
807,572880,6,1,,103516894,4477,Active,,,,,Antibacterial activity against Mycobacterium bovis BCG harboring moaD gene by microplate Alamar Blue assay,Other,18625764.0,
808,572881,6,1,,103516894,4477,Active,,,,,Antibacterial activity against Mycobacterium bovis BCG harboring pil8 gene by microplate Alamar Blue assay,Other,18625764.0,
809,572882,5,2,,103516894,4477,Unspecified,,,,,Antibacterial activity against Mycobacterium tuberculosis H37Rv under aerobic conditions,Other,18625764.0,
810,572883,5,2,,103516894,4477,Unspecified,,,,,Antibacterial activity against Mycobacterium tuberculosis H37Rv under anaerobic conditions by luciferase based low oxygen recovery assay,Other,18625764.0,
811,581111,9,5,,103516894,4477,Active,48429227.0,6774.0,0.25,IC50,Inhibition of STAT3 in human HeLa cells after 24 hrs by luciferase reporter gene assay,Confirmatory,24900231.0,
812,581112,3,9,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 in human HeLa cells at 5 uM after 24 hrs by luciferase reporter gene assay,Other,24900231.0,
813,581113,3,8,,103516894,4477,Unspecified,48429227.0,6774.0,,,Inhibition of STAT3 phosphorylation at Tyr705 in human DU145 cells after 24 hrs by Western blot analysis,Other,24900231.0,
814,581114,3,8,,103516894,4477,Inactive,48429227.0,6774.0,,,Inhibition of STAT3 phosphorylation Ser727 in human DU145 cells after 24 hrs by Western blot analysis,Other,24900231.0,
815,581115,3,6,,103516894,4477,Inactive,,,,,Inhibition of STAT1 phosphorylation at Tyr701 after 2 hrs by Western blot analysis,Other,24900231.0,
816,581116,3,6,,103516894,4477,Inactive,,,,,Inhibition of STAT5 phosphorylation at Tyr694 after 2 hrs by Western blot analysis,Other,24900231.0,
817,581117,1,5,,103516894,4477,Inactive,,,,,Effect on JAK1 protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
818,581118,1,5,,103516894,4477,Inactive,,,,,Effect on JAK1 protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
819,581119,1,5,,103516894,4477,Inactive,,,,,Effect on phosphorylated JAK1 protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
820,581120,1,5,,103516894,4477,Inactive,,,,,Effect on phosphorylated JAK1 protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
821,581121,1,5,,103516894,4477,Inactive,,,,,Effect on JAK2 protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
822,581122,1,5,,103516894,4477,Inactive,,,,,Effect on JAK2 protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
823,581123,1,5,,103516894,4477,Inactive,,,,,Effect on phosphorylated-JAK2 protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
824,581124,1,5,,103516894,4477,Inactive,,,,,Effect on phosphorylated-JAK2 protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
825,581125,1,5,,103516894,4477,Inactive,,,,,Effect on Src protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
826,581126,1,5,,103516894,4477,Inactive,,,,,Effect on Src protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
827,581127,1,5,,103516894,4477,Inactive,,,,,Effect on Tyr416 phosphorylated-Src protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
828,581128,1,5,,103516894,4477,Inactive,,,,,Effect on Tyr416 phosphorylated-Src protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
829,581129,1,5,,103516894,4477,Inactive,,,,,Effect on Tyr5127 phosphorylated-Src protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
830,581130,1,5,,103516894,4477,Inactive,,,,,Effect on Tyr527 phosphorylated-Src protein level in human DU145 cells at 0.1 to 2 uM after 24 hrs by Western blot analysis,Other,24900231.0,
831,581131,7,2,,103516894,4477,Active,,,10.0,IC50,Inhibition of JAK2,Confirmatory,24900231.0,
832,581132,7,2,,103516894,4477,Active,,,10.0,IC50,Inhibition of Src kinase,Confirmatory,24900231.0,
833,581133,3,8,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 nuclear translocation in EGF stimulated human DU145 cells at 1 uM administered before 100 ng/ml EGF stimulation measured after 2 hrs by confocal laser microscopy,Other,24900231.0,
834,581134,3,8,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 interaction with DNA binding site in human DU145 cells at 05 to 10 uM after 2 hrs by EMSA,Other,24900231.0,
835,581135,1,5,,103516894,4477,Active,,,,,Decrease in cyclin D1 protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
836,581136,1,5,,103516894,4477,Active,,,,,Decrease in c-Myc protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
837,581137,1,5,,103516894,4477,Active,,,,,Decrease in Bcl-Xl protein level in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
838,581138,1,5,,103516894,4477,Active,,,,,Downregulation of Mcl-1 protein in human DU145 cells at 0.1 to 2 uM after 2 hrs by Western blot analysis,Other,24900231.0,
839,581139,4,3,,103516894,4477,Active,,,1.4,IC50,Antiproliferative activity against human HeLa cells after 72 hrs by MTT assay,Confirmatory,24900231.0,
840,581140,4,3,,103516894,4477,Active,,,3.0,IC50,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,Confirmatory,24900231.0,
841,581141,4,3,,103516894,4477,Active,,,0.7,IC50,Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay,Confirmatory,24900231.0,
842,581142,4,3,,103516894,4477,Active,,,7.2,IC50,Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay,Confirmatory,24900231.0,
843,581143,4,3,,103516894,4477,Active,,,8.8,IC50,Antiproliferative activity against human A431 cells after 72 hrs by MTT assay,Confirmatory,24900231.0,
844,581144,4,3,,103516894,4477,Active,,,11.7,IC50,Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay,Confirmatory,24900231.0,
845,581145,4,3,,103516894,4477,Active,,,0.7,IC50,Growth inhibition of human DU145 cells assessed as inhibition of colony formation after 11 to 12 days by crystal violet staining based microscopic analysis,Confirmatory,24900231.0,
846,581146,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in G0/G1 phase at 0.2 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
847,581147,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in S phase at 0.2 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
848,581148,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in G2/M phase at 0.2 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
849,581149,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in G0/G1 phase at 0.5 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
850,581150,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in S phase at 0.5 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
851,581151,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in G2/M phase at 0.5 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
852,581152,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in G0/G1 phase at 1 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
853,581153,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in S phase at 1 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
854,581154,1,5,,103516894,4477,Unspecified,,,,,Cell cycle arrest in human DU145 cells assessed as accumulation in G2/M phase at 1 uM after 24 hrs by FACS flow cytometry,Other,24900231.0,
855,581155,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as viable cells at 1 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
856,581156,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as early apoptotic cells at 1 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
857,581157,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as late apoptotic cells at 1 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
858,581158,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as necrotic cells at 1 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
859,581159,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as viable cells at 5 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
860,581160,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as early apoptotic cells at 5 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
861,581161,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as late apoptotic cells at 5 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
862,581162,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as necrotic cells at 5 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
863,581163,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as viable cells at 10 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
864,581164,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as early apoptotic cells at 10 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
865,581165,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as late apoptotic cells at 10 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
866,581166,1,5,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human DU145 cells assessed as necrotic cells at 10 uM after 72 hrs by AnnexinV-propidium iodide based FACS flow cytometry,Other,24900231.0,
867,581167,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of Abl1 after 60 mins by radiometric assay,Confirmatory,24900231.0,
868,581168,7,2,,103516894,4477,Unspecified,,,59.4,IC50,Inhibition of Akt1 after 60 mins by radiometric assay,Confirmatory,24900231.0,
869,581169,7,2,,103516894,4477,Unspecified,,,54.1,IC50,Inhibition of Aurora-A after 60 mins by radiometric assay,Confirmatory,24900231.0,
870,581170,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of B-Raf after 60 mins by radiometric assay,Confirmatory,24900231.0,
871,581171,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of B-Raf V600E mutant after 60 mins by radiometric assay,Confirmatory,24900231.0,
872,581172,7,2,,103516894,4477,Active,,,10.5,IC50,Inhibition of EGFR after 60 mins by radiometric assay,Confirmatory,24900231.0,
873,581173,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of Erk2 after 60 mins by radiometric assay,Confirmatory,24900231.0,
874,581174,7,2,,103516894,4477,Active,,,13.1,IC50,Inhibition of FGFR-1 after 60 mins by radiometric assay,Confirmatory,24900231.0,
875,581175,7,2,,103516894,4477,Unspecified,,,77.5,IC50,Inhibition of GSK3-beta after 60 mins by radiometric assay,Confirmatory,24900231.0,
876,581176,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of Flt3 after 60 mins by radiometric assay,Confirmatory,24900231.0,
877,581177,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of JAK2 after 60 mins by radiometric assay,Confirmatory,24900231.0,
878,581178,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of JNK1 after 60 mins by radiometric assay,Confirmatory,24900231.0,
879,581179,7,2,,103516894,4477,Active,,,27.8,IC50,Inhibition of KIT after 60 mins by radiometric assay,Confirmatory,24900231.0,
880,581180,7,2,,103516894,4477,Active,,,23.8,IC50,Inhibition of LYN after 60 mins by radiometric assay,Confirmatory,24900231.0,
881,581181,4,3,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of MEK after 60 mins by radiometric assay,Confirmatory,24900231.0,
882,581182,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of PDGFR-beta after 60 mins by radiometric assay,Confirmatory,24900231.0,
883,581183,7,2,,103516894,4477,Unspecified,,,83.9,IC50,Inhibition of PDK1 after 60 mins by radiometric assay,Confirmatory,24900231.0,
884,581184,7,2,,103516894,4477,Unspecified,,,67.8,IC50,Inhibition of TIE2 after 60 mins by radiometric assay,Confirmatory,24900231.0,
885,581185,4,4,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of PKC-alpha after 60 mins by radiometric assay,Confirmatory,24900231.0,
886,581186,4,3,,103516894,4477,Unspecified,,,100.0,IC50,Inhibition of Raf Y340D/Y341D mutant after 60 mins by radiometric assay,Confirmatory,24900231.0,
887,581187,7,2,,103516894,4477,Active,,,10.5,IC50,Inhibition of SRC after 60 mins by radiometric assay,Confirmatory,24900231.0,
888,581315,7,2,,103516894,4477,Active,,,23.1,IC50,Inhibition of VEGFR2 after 60 mins by radiometric assay,Confirmatory,24900231.0,
889,581316,1,5,,103516894,4477,Inactive,,,,,Decrease in STAT3 protein level in human DU145 cells after 24 hrs by Western blot analysis,Other,24900231.0,
890,581317,3,8,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 phosphorylation at Tyr705 in human DU145 cells at 2 uM within 2 hrs by Western blot analysis,Other,24900231.0,
891,588334,1,1,,56463356,4477,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
892,588335,1,1,,56463356,4477,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
893,588342,1,1,,56463356,4477,Active,160794.0,,0.2133,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
894,588349,1,1,,90341111,4477,Inconclusive,,,0.7079,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
895,588352,1,2,,56463356,4477,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
896,588354,1,1,,56463356,4477,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
897,588358,1,2,,56463356,4477,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
898,588378,1,1,,90341111,4477,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
899,588391,1,1,,56463356,4477,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
900,588405,1,1,,56463356,4477,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
901,588413,1,2,,56463356,4477,Active,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
902,588436,1,1,,56463356,4477,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
903,588453,1,1,,56463356,4477,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
904,588453,1,1,,85231153,4477,Inconclusive,8659577.0,58819.0,0.0053,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
905,588453,1,1,,90341111,4477,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
906,588456,1,1,,56463356,4477,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
907,588456,1,1,,90341111,4477,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
908,588458,1,1,,56463356,4477,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
909,588473,1,1,,56463356,4477,Active,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
910,588473,1,1,,56463356,4477,Active,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
911,588475,1,2,,56463356,4477,Active,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
912,588475,1,2,,56463356,4477,Active,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
913,588478,1,2,,124799794,4477,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
914,588489,1,1,,56463356,4477,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
915,588492,1,1,,56463356,4477,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
916,588493,1,2,,56463356,4477,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
917,588497,1,2,,56463356,4477,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
918,588497,1,2,,56463356,4477,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
919,588497,1,2,,56463356,4477,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
920,588499,1,3,,56463356,4477,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
921,588499,1,3,,56463356,4477,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
922,588499,1,3,,56463356,4477,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
923,588501,1,2,,56463356,4477,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
924,588501,1,2,,56463356,4477,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
925,588501,1,2,,56463356,4477,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
926,588511,1,2,,56463356,4477,Active,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
927,588513,1,1,,26753613,4477,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
928,588514,1,1,,26753613,4477,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
929,588515,1,1,,26753613,4477,Inconclusive,124375976.0,367.0,1.122,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
930,588516,1,1,,26753613,4477,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
931,588519,1,2,,92125105,4477,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
932,588526,1,1,,26753613,4477,Inconclusive,325495553.0,9971.0,1.4125,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
933,588527,1,1,,26753613,4477,Inconclusive,325495553.0,9971.0,0.2818,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
934,588532,1,1,,26753613,4477,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
935,588533,1,1,,26753613,4477,Inconclusive,311348376.0,2908.0,3.5481,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
936,588534,1,1,,26753613,4477,Inconclusive,216409690.0,5467.0,0.8913,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
937,588535,1,1,,26753613,4477,Inconclusive,216409690.0,5467.0,12.5893,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
938,588536,1,1,,26753613,4477,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
939,588537,1,1,,26753613,4477,Inconclusive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
940,588541,1,1,,26753613,4477,Inconclusive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
941,588543,1,1,,26753613,4477,Inconclusive,216409708.0,7421.0,1.9953,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
942,588544,1,1,,26753613,4477,Inconclusive,325495497.0,6256.0,0.4467,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
943,588545,1,1,,26753613,4477,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
944,588546,1,1,,26753613,4477,Active,325495497.0,6256.0,2.5119,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
945,588547,1,1,,26753613,4477,Inconclusive,189491771.0,7068.0,1.4125,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
946,588549,1,1,,56463356,4477,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
947,588579,1,1,,11111534,4477,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
948,588579,1,1,,56463356,4477,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
949,588579,1,1,,90341111,4477,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
950,588579,1,1,,104171199,4477,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
951,588579,1,1,,124880876,4477,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
952,588590,1,1,,50106712,4477,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
953,588590,1,1,,56463356,4477,Inconclusive,154350220.0,11201.0,50.1187,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
954,588591,1,1,,50106712,4477,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
955,588591,1,1,,56463356,4477,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
956,588621,1,1,,56463356,4477,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
957,588627,1,1,,56463356,4477,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
958,588664,1,2,,56463356,4477,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
959,588664,1,2,,56463356,4477,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
960,588674,1,2,,56463356,4477,Active,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
961,588675,1,1,,56463356,4477,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
962,588676,1,1,,56463356,4477,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
963,588689,1,1,,56463356,4477,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
964,588692,2,1,,56463356,4477,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
965,588726,1,2,,56463356,4477,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
966,588727,1,1,,56463356,4477,Inconclusive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
967,588795,1,1,,56463356,4477,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
968,588795,1,1,,90341111,4477,Inconclusive,4758356.0,2237.0,4.2284,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
969,588814,1,3,,56463356,4477,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
970,588819,1,4,,56463356,4477,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
971,588834,2,1,,26753613,4477,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
972,588834,2,1,,50106712,4477,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
973,588850,1,1,,56463356,4477,Active,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
974,588852,1,3,,56463356,4477,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
975,588855,1,1,,56463356,4477,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
976,588856,1,1,,56463356,4477,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
977,602123,1,1,,56463356,4477,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
978,602141,1,1,,56463356,4477,Active,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
979,602162,1,1,,56463356,4477,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
980,602163,1,1,,56463356,4477,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
981,602179,1,2,,56463356,4477,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
982,602229,1,1,,56463356,4477,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
983,602233,1,1,,56463356,4477,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
984,602244,1,2,,56463356,4477,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
985,602247,1,2,,56463356,4477,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
986,602248,1,2,,56463356,4477,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
987,602250,1,2,,56463356,4477,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
988,602252,1,1,,56463356,4477,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
989,602252,1,1,,56463356,4477,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
990,602261,1,1,,56463356,4477,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
991,602274,1,2,,56463356,4477,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
992,602281,1,1,,56463356,4477,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
993,602281,1,1,,56463356,4477,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
994,602292,1,1,,56463356,4477,Active,118341367.0,7253.0,0.3381,Potency,qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Primary Screen,Confirmatory,,
995,602292,1,1,,90341111,4477,Inconclusive,118341367.0,7253.0,239.34099999999998,Potency,qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Primary Screen,Confirmatory,,
996,602293,1,1,,56463356,4477,Inactive,7704943.0,3973.0,,Potency,qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in HTRF Activity in a Luteinizing Hormone Receptor Cell Line,Confirmatory,,
997,602293,1,1,,90341111,4477,Inactive,7704943.0,3973.0,,Potency,qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in HTRF Activity in a Luteinizing Hormone Receptor Cell Line,Confirmatory,,
998,602310,1,2,,56463356,4477,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
999,602313,1,1,,56463356,4477,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1000,602314,1,2,,92125105,4477,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1001,602329,1,1,,56463356,4477,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1002,602332,1,1,,11111534,4477,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1003,602332,1,1,,56463356,4477,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1004,602332,1,1,,90341111,4477,Inactive,168984549.0,,1.8493,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1005,602332,1,1,,104171199,4477,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1006,602332,1,1,,124880876,4477,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1007,602340,1,2,,56463356,4477,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1008,602342,2,1,,56463356,4477,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1009,602346,1,1,,56463356,4477,Inconclusive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1010,602363,1,1,,56463356,4477,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1011,602393,1,1,,56463356,4477,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1012,602396,1,2,,56463356,4477,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1013,602399,1,2,,56463356,4477,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1014,602405,1,1,,56463356,4477,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1015,602410,1,1,,56463356,4477,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1016,602429,1,1,,56463356,4477,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1017,602438,1,1,,56463356,4477,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1018,602440,1,1,,56463356,4477,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1019,602441,1,1,,56463356,4477,Inactive,118341367.0,7253.0,,Potency,qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Parental Cell Line,Confirmatory,,
1020,602441,1,1,,90341111,4477,Inconclusive,118341367.0,7253.0,37.933,Potency,qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Parental Cell Line,Confirmatory,,
1021,602449,1,2,,56463356,4477,Active,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1022,602481,1,1,,56463356,4477,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1023,606882,3,3,,103516894,4477,Unspecified,,,100.0,CC50,Cytotoxicity against human HepG2(2.2.15) cells after 24 hrs by neutral red dye uptake assay,Confirmatory,21553812.0,
1024,606883,3,2,,103516894,4477,Unspecified,,,,EC50,Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as decrease in extracellular viral DNA measured 24 hrs after last dose,Confirmatory,21553812.0,
1025,623870,1,1,,56463356,4477,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1026,623870,1,1,,56463356,4477,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1027,623877,1,1,,56463356,4477,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1028,623901,1,1,,56463356,4477,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
1029,624030,1,2,,104171199,4477,Active,160794.0,,0.1142,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
1030,624031,1,2,,104171199,4477,Inconclusive,,,2.2794,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
1031,624032,1,2,,104171199,4477,Inconclusive,8393992.0,24660.0,16.1366,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
1032,624037,1,3,,56463356,4477,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1033,624038,1,3,,56463356,4477,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1034,624040,1,3,,56463356,4477,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1035,624044,1,2,,104171199,4477,Active,8393992.0,24660.0,2.51,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
1036,624125,1,4,,56463356,4477,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1037,624126,1,3,,56463356,4477,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1038,624127,1,2,,56463356,4477,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1039,624132,1,1,,56463356,4477,Active,,,3.0,AC50_uM,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1040,624133,1,1,,56463356,4477,Active,,,0.8370000000000001,AC50_uM,Shn3: Dual-Go Shn3RL cells Measured in Cell-Based System Using Plate Reader - 2134-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1041,624134,1,1,,56463356,4477,Active,,,1.62,AC50_uM,Shn3: Cytotox assay Measured in Cell-Based System Using Plate Reader - 2134-03_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1042,624146,1,1,,90341111,4477,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
1043,624147,1,1,,90341111,4477,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
1044,624148,1,2,,90341111,4477,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
1045,624149,1,1,,90341111,4477,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
1046,624156,1,1,,85788811,4477,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1047,624168,1,1,,56463356,4477,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1048,624169,1,1,,56463356,4477,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1049,624170,1,1,,56463356,4477,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1050,624170,1,1,,104171199,4477,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1051,624171,1,1,,56463356,4477,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1052,624172,1,1,,56463356,4477,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1053,624172,1,1,,104171199,4477,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1054,624173,1,3,,56463356,4477,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1055,624173,1,3,,104171199,4477,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1056,624178,1,1,,56463356,4477,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1057,624202,1,1,,56463356,4477,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1058,624204,1,2,,56463356,4477,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1059,624246,1,1,,56463356,4477,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1060,624263,1,1,,56463356,4477,Inconclusive,3063388.0,5071.0,0.4467,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1061,624263,1,1,,56463356,4477,Inconclusive,37183032.0,,0.4467,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1062,624263,1,1,,124880876,4477,Inconclusive,3063388.0,5071.0,2.8184,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1063,624263,1,1,,124880876,4477,Inconclusive,37183032.0,,2.8184,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1064,624267,1,2,,56463356,4477,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1065,624267,1,2,,56463356,4477,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1066,624268,1,3,,56463356,4477,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1067,624288,1,1,,56463356,4477,Active,52000961.0,2778.0,1.9953,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1068,624296,1,1,,26753613,4477,Inconclusive,7705682.0,51053.0,0.2986,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1069,624296,1,1,,56463356,4477,Inconclusive,7705682.0,51053.0,0.1158,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1070,624296,1,1,,104171199,4477,Inconclusive,7705682.0,51053.0,0.1971,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1071,624297,1,1,,26753613,4477,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1072,624297,1,1,,56463356,4477,Inconclusive,7705682.0,51053.0,0.5174,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1073,624297,1,1,,104171199,4477,Active,7705682.0,51053.0,3.1623,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1074,624304,1,2,,56463356,4477,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1075,624330,1,2,,56463356,4477,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1076,624349,1,2,,92125105,4477,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1077,624349,1,2,,92307851,4477,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1078,624349,1,2,,121362776,4477,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1079,624352,1,1,,56463356,4477,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1080,624354,1,1,,56463356,4477,Active,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1081,624377,1,1,,56463356,4477,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
1082,624414,1,1,,56463356,4477,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1083,624415,1,2,,56463356,4477,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1084,624416,1,1,,56463356,4477,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
1085,624417,1,1,,56463356,4477,Inconclusive,1724069.0,2740.0,1.5849,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1086,624418,1,1,,56463356,4477,Inconclusive,,,1.9953,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1087,624455,1,1,,90341111,4477,Inactive,299681.0,1812.0,,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
1088,624463,1,1,,56463356,4477,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1089,624464,1,1,,56463356,4477,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1090,624465,1,1,,56463356,4477,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1091,624466,1,3,,56463356,4477,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1092,624467,1,1,,56463356,4477,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
1093,624483,1,1,,56463356,4477,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1094,624504,1,1,,56463356,4477,Active,,,,,Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay,Screening,,
1095,642456,3,3,,103516894,4477,Active,,,,EC50,Antiviral activity against HCV genotype 1b infected in Ava5 cells assessed as inhibition of viral replication after 3 days by blot hybridization analysis,Confirmatory,22059983.0,
1096,642457,3,3,,103516894,4477,Active,,,10.0,CC50,Cytotoxicity against human Ava5 cells after 3 days by neutral red dye assay,Confirmatory,22059983.0,
1097,642458,1,3,,103516894,4477,Unspecified,,,,,"Selectivity index, ratio of CC50 for human Ava5 cells to EC50 for HCV genotype 1b infected in human Ava5 cells",Other,22059983.0,
1098,642462,1,3,,103516894,4477,Unspecified,,,,,Aqueous solubility of the compound,Other,22059983.0,
1099,651550,1,1,,56463356,4477,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1100,651560,1,1,,56463356,4477,Active,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1101,651572,1,2,,56463356,4477,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1102,651582,1,1,,56463356,4477,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1103,651602,1,1,,56463356,4477,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1104,651602,1,1,,56463356,4477,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1105,651602,1,1,,56463356,4477,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1106,651610,2,1,,56463356,4477,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1107,651631,4,1,,144203760,4477,Active,269849759.0,7157.0,0.2985,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1108,651631,4,1,,144211066,4477,Active,269849759.0,7157.0,0.6113,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1109,651632,4,1,,144203760,4477,Active,296439460.0,79915.0,0.075,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1110,651632,4,1,,144211066,4477,Inactive,296439460.0,79915.0,10.8707,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1111,651633,4,1,,144203760,4477,Active,,,0.0944,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1112,651633,4,1,,144211066,4477,Active,,,0.0969,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1113,651634,4,1,,144203760,4477,Active,,,0.5956,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1114,651634,4,1,,144211066,4477,Active,,,2.4337,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1115,651635,1,3,,11111534,4477,Active,171543895.0,6311.0,3.9811,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1116,651635,1,3,,56463356,4477,Inconclusive,171543895.0,6311.0,0.7079,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1117,651635,1,3,,90341111,4477,Inconclusive,171543895.0,6311.0,1.4125,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1118,651636,1,1,,56463356,4477,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1119,651640,1,1,,56463356,4477,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1120,651644,1,1,,56463356,4477,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1121,651647,1,1,,56463356,4477,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1122,651654,1,1,,56463356,4477,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1123,651658,1,1,,56463356,4477,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1124,651661,2,1,,56463356,4477,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1125,651687,1,1,,56463356,4477,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1126,651699,1,1,,56463356,4477,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1127,651699,1,1,,56463356,4477,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1128,651702,1,2,,56463356,4477,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1129,651704,2,1,,56463356,4477,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1130,651710,1,1,,56463356,4477,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1131,651711,2,1,,56463356,4477,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1132,651718,1,2,,56463356,4477,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1133,651719,1,2,,56463356,4477,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
1134,651723,1,1,,56463356,4477,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
1135,651724,1,1,,56463356,4477,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1136,651725,1,1,,56463356,4477,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1137,651741,1,1,,144203760,4477,Active,20149576.0,4780.0,3.0638,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1138,651743,1,1,,26753613,4477,Active,269849759.0,7157.0,0.8913,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1139,651749,1,1,,26753613,4477,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1140,651751,1,1,,26753613,4477,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1141,651768,1,2,,56463356,4477,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1142,651777,1,1,,26753613,4477,Active,51095037.0,196.0,1.4125,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1143,651778,1,1,,26753613,4477,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1144,651800,1,1,,56463356,4477,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1145,651819,1,1,,56463356,4477,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1146,651820,1,1,,56463356,4477,Active,,,1.2589,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1147,651821,2,4,,56463356,4477,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1148,651828,1,2,,121361717,4477,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
1149,651838,1,1,,26753613,4477,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1150,651838,1,1,1.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1151,651838,1,1,2.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1152,651838,1,1,3.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1153,651838,1,1,4.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1154,651838,1,1,5.0,26753613,4477,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1155,651838,1,1,6.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1156,651838,1,1,7.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1157,651838,1,1,8.0,26753613,4477,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1158,651957,1,1,,56463356,4477,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1159,651958,1,1,,56463356,4477,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1160,651965,1,1,,56463356,4477,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1161,651999,1,1,,56463356,4477,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1162,652010,1,1,,56463356,4477,Active,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1163,652017,1,1,,56463356,4477,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1164,652025,1,1,,56463356,4477,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1165,652039,1,1,,56463356,4477,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1166,652048,1,2,,56463356,4477,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1167,652048,1,2,,144203760,4477,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1168,652051,1,1,,56463356,4477,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1169,652051,1,1,,144203760,4477,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1170,652054,1,1,,56463356,4477,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1171,652067,1,4,,56463356,4477,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1172,652104,1,1,,56463356,4477,Inconclusive,20140568.0,23435.0,0.8913,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1173,652105,1,1,,56463356,4477,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1174,652106,1,1,,56463356,4477,Inactive,586067.0,6622.0,3.9811,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1175,652106,1,1,,90341111,4477,Inactive,586067.0,6622.0,0.13,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1176,652115,1,1,,56463356,4477,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1177,652126,1,3,,56463356,4477,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1178,652134,1,1,,56463356,4477,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1179,652136,1,2,,56463356,4477,Inactive,20070193.0,2516.0,,,"Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay",Screening,,
1180,652154,1,1,,56463356,4477,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1181,652162,2,1,,56463356,4477,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1182,652163,1,1,,56463356,4477,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1183,652197,1,1,,56463356,4477,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1184,652257,1,1,,56463356,4477,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1185,686940,1,1,,56463356,4477,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1186,686964,1,1,,56463356,4477,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1187,686970,1,2,,56463356,4477,Active,49168486.0,3417.0,0.3663,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1188,686971,1,2,,56463356,4477,Active,,,0.3663,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1189,686977,2,1,,49698803,4477,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1190,686978,1,1,,56463356,4477,Active,79154014.0,55775.0,0.5805,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1191,686978,1,1,,124880876,4477,Active,79154014.0,55775.0,2.9093,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1192,686978,1,1,,144203760,4477,Active,79154014.0,55775.0,0.1679,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1193,686979,1,1,,56463356,4477,Active,79154014.0,55775.0,0.5805,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1194,686979,1,1,,124880876,4477,Active,79154014.0,55775.0,5.8048,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1195,686979,1,1,,144203760,4477,Active,79154014.0,55775.0,0.5957,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1196,686992,2,1,,56463356,4477,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
1197,687014,1,1,,56463356,4477,Active,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1198,687016,1,1,,56463356,4477,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1199,687035,1,1,,163564820,4477,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1200,687037,1,3,,163564820,4477,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
1201,704578,1,2,,103516894,4477,Active,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing pH sensitive ratiometric GFP assessed as reduction of intrabacterial pH at 0.002 to 20 ug/ml after 16 hrs at pH 7.5 by spectrofluorimetric analysis,Other,22096616.0,
1202,704582,1,2,,103516894,4477,Inactive,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as disruption of membrane potential at 0.002 to 20 ug/ml after 20 mins at pH 4.5 by DiOC2-based spectrofluorimetric analysis,Other,22096616.0,
1203,704583,1,2,,103516894,4477,Active,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as disruption of membrane potential at 0.002 to 20 ug/ml after 20 mins at pH 5.5 by DiOC2-based spectrofluorimetric analysis,Other,22096616.0,
1204,704586,1,2,,103516894,4477,Unspecified,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as disruption of membrane potential after 20 mins at pH 7.4 by DiOC2-based spectrofluorimetric analysis,Other,22096616.0,
1205,705475,5,1,,103516894,4477,Active,,,,MIC50,Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites infected in HFF cells assessed as [3H]-uracil incorporation after 24 hrs by scintillation luminescence counter,Confirmatory,22970937.0,
1206,720504,1,1,,56463356,4477,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1207,720508,1,1,,56463356,4477,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1208,720509,1,1,,56463356,4477,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1209,720511,1,1,,56463356,4477,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1210,720516,2,1,,144203760,4477,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1211,720516,2,1,,144211066,4477,Inconclusive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1212,720532,1,1,,11111534,4477,Active,420597.0,,1.9953,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1213,720532,1,1,,124880876,4477,Active,420597.0,,5.0119,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1214,720532,1,1,,144203760,4477,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1215,720533,1,1,,11111534,4477,Active,,,1.2589,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1216,720533,1,1,,124880876,4477,Active,,,7.0795,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1217,720533,1,1,,144203760,4477,Active,,,1.122,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1218,720538,1,2,,90341111,4477,Inactive,220983390.0,410.0,37.933,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1219,720542,1,2,,56463356,4477,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1220,720543,1,1,,56463356,4477,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1221,720551,1,2,,56463356,4477,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1222,720552,2,1,,144203760,4477,Active,269849759.0,7157.0,0.47307899999999997,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1223,720552,2,1,,144211066,4477,Active,269849759.0,7157.0,0.48557700000000004,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1224,720553,1,2,,56463356,4477,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1225,720559,1,2,,90341111,4477,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1226,720572,1,2,,90341111,4477,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1227,720573,1,2,,90341111,4477,Inconclusive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1228,720579,2,1,,56463356,4477,Inconclusive,222762.0,3707576.0,1.4125,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1229,720579,2,1,,124880876,4477,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1230,720580,1,1,,56463356,4477,Inconclusive,222762.0,3707576.0,1.7783,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1231,720580,1,1,,124880876,4477,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1232,720582,1,1,,56463356,4477,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1233,720596,1,1,,56463356,4477,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1234,720634,2,1,,144203760,4477,Inconclusive,,,0.1333,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1235,720634,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1236,720635,2,1,,144203760,4477,Active,,,0.0266,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1237,720635,2,1,,144211066,4477,Active,,,0.0097,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1238,720636,1,1,,144203760,4477,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1239,720637,2,1,,144203760,4477,Active,,,0.0348017,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1240,720637,2,1,,144211066,4477,Inconclusive,,,0.017228900000000002,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1241,720641,1,2,,92307851,4477,Active,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
1242,720647,1,2,,56463356,4477,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1243,720648,1,1,,56463356,4477,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1244,720653,1,1,,26753613,4477,Inconclusive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1245,720659,1,1,,26753613,4477,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1246,720674,2,2,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1247,720674,2,2,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1248,720675,2,2,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1249,720675,2,2,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1250,720678,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1251,720678,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1252,720679,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1253,720679,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1254,720680,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1255,720680,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1256,720681,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1257,720681,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1258,720682,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1259,720682,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1260,720683,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1261,720683,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1262,720684,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1263,720684,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1264,720685,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1265,720685,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1266,720686,2,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1267,720686,2,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1268,720687,2,2,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1269,720687,2,2,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1270,720691,4,1,,144203760,4477,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1271,720691,4,1,,144211066,4477,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1272,720692,3,1,,144203760,4477,Inconclusive,311348376.0,2908.0,0.0952,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1273,720692,3,1,,144211066,4477,Inconclusive,311348376.0,2908.0,0.1737,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1274,720693,3,1,,144203760,4477,Inconclusive,,,0.2683,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1275,720693,3,1,,144211066,4477,Active,,,0.2754,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1276,720700,1,4,,56463356,4477,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1277,720702,1,1,,56463356,4477,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1278,720704,1,4,,56463356,4477,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1279,720707,1,2,,56463356,4477,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1280,720708,1,2,,56463356,4477,Inconclusive,32171491.0,11069.0,79.4328,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1281,720709,1,2,,56463356,4477,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1282,720711,1,2,,56463356,4477,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1283,720717,1,3,,92125105,4477,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1284,720717,1,3,,92307851,4477,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1285,720719,2,1,,144203760,4477,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1286,720719,2,1,,144211066,4477,Inconclusive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1287,720725,2,1,,144203760,4477,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1288,720725,2,1,,144211066,4477,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1289,727560,1,2,,103516894,4477,Active,,,,,"Antitumor activity against human ER negative MDA-MB-231 cells xenografted in nude mouse assessed as inhibition of tumor growth at 75 mg/kg, po qd for 5 days",Other,23459613.0,
1290,727562,1,2,,103516894,4477,Active,,,,,"Antitumor activity against human ER negative MDA-MB-231 cells xenografted in nude mouse assessed as inhibition of tumor growth at 12.5 mg/kg, ip qd for 5 days",Other,23459613.0,
1291,727564,1,2,,103516894,4477,Unspecified,,,,,Induction of apoptosis in human ER negative MDA-MB-231 cells assessed as cleavage of caspase-3 after 48 hrs,Other,23459613.0,
1292,727568,1,2,,103516894,4477,Active,,,,,Antiproliferative activity against human ER negative MDA-MB-231 cells at 10 to 20 uM after 24 hrs by MTT assay,Other,23459613.0,
1293,727569,1,6,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 promoter activity in human ER negative MDA-MB-231 cells after 24 hrs by dual luciferase reporter assay,Other,23459613.0,
1294,727570,1,6,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 promoter activity in human ER negative MDA-MB-231 cells at 20 uM after 24 hrs by dual luciferase reporter assay,Other,23459613.0,
1295,727571,1,6,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 promoter activity in human ER negative MDA-MB-231 cells at 10 uM after 24 hrs by dual luciferase reporter assay,Other,23459613.0,
1296,727572,1,2,,103516894,4477,Unspecified,,,,,Solubility of the compound in water,Other,23459613.0,
1297,727573,1,6,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 in human ER negative MDA-MB-231 cells assessed as reduction of total STAT3 level at 1 to 10 uM after 24 hrs by Western blot analysis,Other,23459613.0,
1298,727574,1,2,,103516894,4477,Active,,,,,Induction of morphological changes in human ER negative MDA-MB-231 cells at 1 to 10 uM after 48 hrs by light microscopic analysis,Other,23459613.0,
1299,727575,1,2,,103516894,4477,Active,,,,,Induction of apoptosis in human ER negative MDA-MB-231 cells at 1 to 10 uM after 48 hrs by light microscopic analysis,Other,23459613.0,
1300,727576,1,2,,103516894,4477,Active,,,,,Antiproliferative activity against human ER negative MDA-MB-231 cells at 1 to 10 uM after 48 hrs by light microscopic analysis,Other,23459613.0,
1301,727577,1,3,,103516894,4477,Active,,,1.73,IC50,Cytotoxicity against human PANC1 cells after 72 hrs by MTS assay,Confirmatory,23459613.0,
1302,727578,1,6,,103516894,4477,Active,48429227.0,6774.0,,,Inhibition of STAT3 in human ER negative MDA-MB-231 cells assessed as reduction of phosphorylated STAT3 at Tyr-705 level at 1 to 10 uM after 24 hrs by Western blot analysis,Other,23459613.0,
1303,727579,1,2,,103516894,4477,Active,,,1.47,IC50,Cytotoxicity against human AsPC1 cells after 72 hrs by MTS assay,Confirmatory,23459613.0,
1304,727580,1,2,,103516894,4477,Active,,,1.06,IC50,Cytotoxicity against human ER positive MCF7 cells after 72 hrs by MTS assay,Confirmatory,23459613.0,
1305,727581,1,2,,103516894,4477,Active,,,0.79,IC50,Cytotoxicity against human ER negative MDA-MB-231 cells after 72 hrs by MTS assay,Confirmatory,23459613.0,
1306,732326,1,3,,103516894,4477,Active,,,1.73,IC50,CYtotoxicity against human PANC1 cells by MTS assay,Confirmatory,23416191.0,
1307,732327,1,2,,103516894,4477,Active,,,1.47,IC50,CYtotoxicity against human AsPC1 cells by MTS assay,Confirmatory,23416191.0,
1308,732328,1,2,,103516894,4477,Active,,,0.79,IC50,CYtotoxicity against ER-negative human MDA-MB-231 cells by MTS assay,Confirmatory,23416191.0,
1309,732759,1,2,,103516894,4477,Active,,,1.06,IC50,CYtotoxicity against ER-positive human MCF7 cells by MTS assay,Confirmatory,23416191.0,
1310,741323,1,2,,103516894,4477,Active,,,0.4,IC50,Inhibition of Wnt3A/beta-casein signaling in HEK293 cells after 8 hrs by TOPflash reporter assay,Confirmatory,23453073.0,
1311,741324,1,6,,103516894,4477,Active,92058705.0,8321.0,,,Induction of internalization of Frizzled1-GFP (unknown origin) expressed in human U2OS cells at 12.5 uM after 6 hrs by confocal microscopy,Other,23453073.0,
1312,743012,3,1,,144203760,4477,Active,,,0.4216,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1313,743012,3,1,,144211066,4477,Active,,,0.7696,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1314,743014,3,1,,144203760,4477,Active,,,0.4731,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1315,743014,3,1,,144211066,4477,Active,,,0.6859,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1316,743015,3,1,,144203760,4477,Active,,,0.4731,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1317,743015,3,1,,144211066,4477,Active,,,0.6113,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1318,743033,3,1,,144203760,4477,Active,,,1.5089,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1319,743033,3,1,,144211066,4477,Active,,,0.4364,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1320,743035,2,1,,144203760,4477,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1321,743035,2,1,,144211066,4477,Inconclusive,124375976.0,367.0,0.0871,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1322,743036,2,1,,144203760,4477,Inconclusive,124375976.0,367.0,0.1199,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1323,743036,2,1,,144211066,4477,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1324,743040,3,1,,144203760,4477,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1325,743040,3,1,,144211066,4477,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1326,743041,3,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1327,743041,3,1,,144211066,4477,Active,,,1.5355,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1328,743042,3,1,,144203760,4477,Inactive,124375976.0,367.0,0.075,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1329,743042,3,1,,144211066,4477,Inconclusive,124375976.0,367.0,1.5355,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1330,743053,2,1,,144203760,4477,Inconclusive,124375976.0,367.0,0.15089,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1331,743053,2,1,,144211066,4477,Inconclusive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1332,743054,2,1,,144203760,4477,Inconclusive,124375976.0,367.0,0.0491587,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1333,743054,2,1,,144211066,4477,Inconclusive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1334,743063,2,1,,144203760,4477,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1335,743063,2,1,,144211066,4477,Inconclusive,124375976.0,367.0,0.5494100000000001,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1336,743064,3,1,,144203760,4477,Active,,,0.6682,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1337,743064,3,1,,144211066,4477,Active,,,0.8635,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1338,743065,3,1,,144203760,4477,Active,399498506.0,24831.0,0.3349,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1339,743065,3,1,,144211066,4477,Active,399498506.0,24831.0,0.4328,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1340,743066,3,1,,144203760,4477,Inconclusive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1341,743066,3,1,,144211066,4477,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1342,743067,2,1,,144203760,4477,Inconclusive,399498506.0,24831.0,0.28725500000000004,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1343,743067,2,1,,144211066,4477,Inconclusive,399498506.0,24831.0,0.252886,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1344,743069,2,1,,144203760,4477,Inactive,348019627.0,2099.0,0.1199,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1345,743069,2,1,,144211066,4477,Inconclusive,348019627.0,2099.0,0.0275,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1346,743074,2,1,,144203760,4477,Inconclusive,,,0.0601,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1347,743074,2,1,,144211066,4477,Inconclusive,,,0.0389,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1348,743075,2,1,,144203760,4477,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1349,743075,2,1,,144211066,4477,Inconclusive,348019627.0,2099.0,1.23,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1350,743077,2,1,,144203760,4477,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1351,743077,2,1,,144211066,4477,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1352,743078,2,1,,144203760,4477,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1353,743078,2,1,,144211066,4477,Inconclusive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1354,743079,3,1,,144203760,4477,Inconclusive,348019627.0,2099.0,0.5956,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1355,743079,3,1,,144211066,4477,Inconclusive,348019627.0,2099.0,1.9331,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1356,743080,3,1,,144203760,4477,Active,348019627.0,2099.0,0.8413,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1357,743080,3,1,,144211066,4477,Inconclusive,348019627.0,2099.0,1.7229,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1358,743081,3,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1359,743081,3,1,,144211066,4477,Inconclusive,,,1.0871,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1360,743083,3,1,,144203760,4477,Inactive,119597822.0,1588.0,0.0168,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1361,743083,3,1,,144211066,4477,Active,119597822.0,1588.0,1.9331,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1362,743084,3,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1363,743084,3,1,,144211066,4477,Inconclusive,,,1.9331,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1364,743085,3,1,,144203760,4477,Active,51095037.0,196.0,0.2113,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1365,743085,3,1,,144211066,4477,Inconclusive,51095037.0,196.0,0.2169,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1366,743086,3,1,,144203760,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1367,743086,3,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1368,743091,2,1,,144203760,4477,Active,348019627.0,2099.0,0.943918,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1369,743091,2,1,,144211066,4477,Inconclusive,348019627.0,2099.0,1.04614,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1370,743094,3,1,,144203760,4477,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1371,743094,3,1,,144211066,4477,Inconclusive,216409692.0,5468.0,0.5494,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1372,743122,2,1,,144203760,4477,Active,51095037.0,196.0,0.181246,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1373,743122,2,1,,144211066,4477,Active,51095037.0,196.0,0.19331199999999998,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1374,743126,1,1,,56463356,4477,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1375,743139,2,1,,144203760,4477,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1376,743139,2,1,,144211066,4477,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1377,743140,2,1,,144203760,4477,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1378,743140,2,1,,144211066,4477,Inconclusive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1379,743191,3,1,,144211066,4477,Inconclusive,216409692.0,5468.0,1.3801,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1380,743191,3,1,,170465184,4477,Inconclusive,216409692.0,5468.0,1.6356,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1381,743194,3,1,,144211066,4477,Active,,,0.12300000000000001,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1382,743194,3,1,,170465184,4477,Active,,,0.461,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1383,743199,2,1,,144211066,4477,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1384,743199,2,1,,170465184,4477,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1385,743202,4,1,,144211066,4477,Inconclusive,20149576.0,4780.0,3.4376,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1386,743202,4,1,,170465184,4477,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1387,743203,3,1,,144211066,4477,Inconclusive,,,1.3685,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1388,743203,3,1,,170465184,4477,Inconclusive,,,0.6511,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1389,743205,1,1,,90341111,4477,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1390,743205,1,1,,90341111,4477,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1391,743206,1,1,,90341111,4477,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1392,743206,1,1,,90341111,4477,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1393,743207,1,1,,90341111,4477,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1394,743207,1,1,,90341111,4477,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1395,743209,3,1,,144211066,4477,Active,,,0.309,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1396,743209,3,1,,170465184,4477,Inconclusive,,,0.6511,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1397,743210,4,1,,144211066,4477,Inconclusive,4504517.0,3315.0,0.4364,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1398,743210,4,1,,170465184,4477,Inconclusive,4504517.0,3315.0,1.1579,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1399,743211,3,1,,144211066,4477,Active,,,0.2187,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1400,743211,3,1,,170465184,4477,Active,,,0.2592,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1401,743212,3,1,,144211066,4477,Inconclusive,216409690.0,5467.0,1.3801,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1402,743212,3,1,,170465184,4477,Inconclusive,216409690.0,5467.0,2.9085,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1403,743213,3,1,,144211066,4477,Inconclusive,,,0.0275,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1404,743213,3,1,,170465184,4477,Active,,,1.6356,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1405,743215,3,1,,144211066,4477,Inconclusive,216409690.0,5467.0,1.3801,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1406,743215,3,1,,170465184,4477,Inconclusive,216409690.0,5467.0,1.8351,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1407,743217,3,1,,144211066,4477,Inconclusive,325495553.0,9971.0,4.8966,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1408,743217,3,1,,170465184,4477,Inconclusive,325495553.0,9971.0,4.6096,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1409,743218,3,1,,144211066,4477,Active,,,1.3801,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1410,743218,3,1,,170465184,4477,Active,,,1.1579,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1411,743219,3,1,,144211066,4477,Inconclusive,20149576.0,4780.0,4.85577,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1412,743219,3,1,,170465184,4477,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1413,743220,3,1,,144211066,4477,Inconclusive,325495553.0,9971.0,1.7374,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1414,743220,3,1,,170465184,4477,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1415,743221,3,1,,144211066,4477,Inconclusive,,,1.5484,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1416,743221,3,1,,170465184,4477,Active,,,3.2634,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1417,743222,3,1,,144211066,4477,Inconclusive,216409708.0,7421.0,27.5357,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1418,743222,3,1,,170465184,4477,Inconclusive,216409708.0,7421.0,1.1579,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1419,743223,3,1,,144211066,4477,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1420,743223,3,1,,170465184,4477,Inconclusive,216409708.0,7421.0,2.0769,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1421,743224,3,1,,144211066,4477,Active,,,0.5494,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1422,743224,3,1,,170465184,4477,Active,,,0.6511,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1423,743225,3,1,,144211066,4477,Inconclusive,,,0.4364,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1424,743225,3,1,,170465184,4477,Inconclusive,,,18.5108,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1425,743226,2,1,,144211066,4477,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1426,743226,2,1,,170465184,4477,Inconclusive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1427,743227,2,1,,144211066,4477,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1428,743227,2,1,,170465184,4477,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1429,743228,3,1,,144211066,4477,Inconclusive,4504517.0,3315.0,27.5357,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1430,743228,3,1,,170465184,4477,Inconclusive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1431,743238,1,1,,56463356,4477,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
1432,743239,2,1,,144211066,4477,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1433,743239,2,1,,170465184,4477,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1434,743240,2,1,,144211066,4477,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1435,743240,2,1,,170465184,4477,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1436,743241,2,1,,144211066,4477,Inconclusive,216409708.0,7421.0,0.9048219999999999,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1437,743241,2,1,,170465184,4477,Inconclusive,216409708.0,7421.0,1.63555,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1438,743242,2,1,,144211066,4477,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1439,743242,2,1,,170465184,4477,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1440,743244,1,1,,90341111,4477,Inconclusive,,,6.3096,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1441,743244,1,1,,144203760,4477,Inconclusive,,,28.1838,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1442,743247,1,2,,56463356,4477,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1443,743255,1,1,,56463356,4477,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1444,743266,1,2,,56463356,4477,Inactive,296080761.0,5745.0,0.7667,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1445,743269,1,1,,56463356,4477,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1446,743269,1,1,,56463356,4477,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1447,743279,1,2,,56463356,4477,Active,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1448,743287,1,1,,56463356,4477,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
1449,743288,1,1,,26753613,4477,Active,,,7.0795,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1450,743292,1,1,,26753613,4477,Inconclusive,,,1.5849,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1451,743344,1,1,,174006693,4477,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1452,743345,1,1,,174006693,4477,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1453,743346,1,1,,174006693,4477,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
1454,743347,1,1,,174006693,4477,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1455,743364,1,2,,174006693,4477,Inactive,,,,Potency,qHTS profiling of inhibitors of Plasmodium falciparum (3D7) proliferation (acoustic dispense),Confirmatory,,
1456,743365,1,2,,174006693,4477,Inactive,,,12.9809,Potency,qHTS profiling of inhibitors of Plasmodium falciparum (DD2) proliferation (acoustic dispense),Confirmatory,,
1457,743366,1,2,,174006693,4477,Inactive,,,,Potency,qHTS profiling of inhibitors of Plasmodium falciparum (HB3) proliferation (acoustic dispense),Confirmatory,,
1458,743397,1,1,,56463356,4477,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1459,743398,1,1,,56463356,4477,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1460,743417,1,1,,56463356,4477,Active,,,3.0,AC50_uM,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_Dose_DryPowder_Activity_Set2,Confirmatory,,
1461,1053175,2,1,,178127254,4477,Active,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
1462,1053197,1,1,,56463356,4477,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1463,1094681,2,1,,103516894,4477,Unspecified,,,,,"Octanol-water partition coefficient, log P of the compound",Other,,
1464,1117298,1,2,,170465184,4477,Inactive,,,19.9526,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
1465,1117304,1,2,,170465184,4477,Active,,,0.8913,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
1466,1117305,1,2,,170465184,4477,Active,,,1.0,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
1467,1117308,1,1,,170465184,4477,Active,,,2.65875,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, ratio channel",Confirmatory,,
1468,1117309,1,1,,170465184,4477,Inactive,,,2.98317,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, blue channel",Confirmatory,,
1469,1117310,1,1,,170465184,4477,Inactive,,,19.9526,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
1470,1117312,1,1,,170465184,4477,Active,,,1.0,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
1471,1117314,1,1,,170465184,4477,Inactive,,,0.891251,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
1472,1117316,1,1,,170465184,4477,Inactive,,,,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 4, green channel",Confirmatory,,
1473,1117322,1,1,,170465184,4477,Active,,,0.001,IC50,RKO viability from Cell TiterGlo-IC50,Confirmatory,,
1474,1117323,1,1,,170465184,4477,Active,,,0.47285,IC50,SNU-C1 viability from Cell TiterGlo-IC50,Confirmatory,,
1475,1117324,1,1,,170465184,4477,Inactive,,,5.8131,IC50,VEGF stimulated ADSC/ECFC co-culture nuclear area decrease (viability)-IC50,Confirmatory,,
1476,1117325,1,1,,170465184,4477,Active,,,1.5708,IC50,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
1477,1117326,1,1,,170465184,4477,Active,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
1478,1117327,1,1,,170465184,4477,Inactive,,,20.0,IC50,alkaline phosphatase stimulation in WNT3A conditioned C2C12 cells-IC50,Confirmatory,,
1479,1117328,1,1,,170465184,4477,Inactive,,,,,human p70S6K1 kinase inhibition-screen,Screening,,
1480,1117329,1,1,,170465184,4477,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
1481,1117330,1,1,,170465184,4477,Active,,,4.0732099999999996,IC50,HT-29 viability from Cell TiterGlo-IC50,Confirmatory,,
1482,1117332,1,1,,170465184,4477,Active,,,0.00144,IC50,HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1483,1117334,1,1,,170465184,4477,Active,,,0.00826,IC50,Colo320 viability from Cell TiterGlo-IC50,Confirmatory,,
1484,1117336,1,1,,170465184,4477,Active,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
1485,1117337,1,1,,170465184,4477,Active,,,0.11199999999999999,IC50,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-IC50,Confirmatory,,
1486,1117338,1,1,,170465184,4477,Active,,,0.001,IC50,SW480 viability from Cell TiterGlo-IC50,Confirmatory,,
1487,1117339,1,1,,170465184,4477,Active,,,0.00295,IC50,GSK3B-pretreated HCT116 viability from Cell TiterGlo-IC50,Confirmatory,,
1488,1117340,1,1,,170465184,4477,Active,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
1489,1117341,1,1,,170465184,4477,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
1490,1117342,1,1,,170465184,4477,Active,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
1491,1117343,1,1,,170465184,4477,Active,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
1492,1117346,1,1,,170465184,4477,Active,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
1493,1117347,1,1,,170465184,4477,Active,,,0.14400000000000002,IC50,Decreased HeLa cell count-IC50,Confirmatory,,
1494,1117348,1,1,,170465184,4477,Inactive,,,10.0,IC50,Increased HeLa cells in S-phase-IC50,Confirmatory,,
1495,1117349,1,1,,170465184,4477,Inactive,,,10.0,IC50,Increased HeLa cells with 2N DNA content-IC50,Confirmatory,,
1496,1117350,1,1,,170465184,4477,Inactive,,,10.0,IC50,Increased chromatin condensation in HeLa cells-IC50,Confirmatory,,
1497,1117351,1,1,,170465184,4477,Inactive,,,10.0,IC50,Increased HeLa cells with 4N DNA content-IC50,Confirmatory,,
1498,1117352,1,1,,170465184,4477,Active,,,0.00349,IC50,DLD-1 viability from Cell TiterGlo-IC50,Confirmatory,,
1499,1117353,1,1,,170465184,4477,Inactive,,,,,human KDR kinase inhibition-screen,Screening,,
1500,1117354,1,1,,170465184,4477,Inactive,,,,,human JAK2 kinase inhibition-screen,Screening,,
1501,1117355,1,1,,170465184,4477,Inactive,,,,,human GSK3B kinase inhibition-screen,Screening,,
1502,1117356,1,1,,170465184,4477,Inactive,,,,,human FLT3 kinase inhibition-screen,Screening,,
1503,1133091,1,1,,103516894,4477,Unspecified,,,,,Cestodicidal activity against Hymenolepis nana infected in po dosed rat assessed as reduction in 98 to 100% of worm load after 3 days,Other,722724.0,
1504,1149686,1,1,,103516894,4477,Unspecified,,,,,Cestodicidal activity against Hymenolepis nana infected in po dosed rat administered as single dose,Other,874957.0,
1505,1159509,1,1,,144211066,4477,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1506,1159509,1,1,,170465184,4477,Inconclusive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1507,1159515,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1508,1159515,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1509,1159516,1,1,,144211066,4477,Inconclusive,119611100.0,22926.0,10.9622,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1510,1159516,1,1,,170465184,4477,Inconclusive,119611100.0,22926.0,5.2170000000000005,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1511,1159517,1,1,,144211066,4477,Inconclusive,,,0.2454,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1512,1159517,1,1,,170465184,4477,Inconclusive,,,0.3292,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1513,1159518,1,1,,144211066,4477,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1514,1159518,1,1,,170465184,4477,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1515,1159519,1,1,,144211066,4477,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1516,1159519,1,1,,170465184,4477,Inconclusive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1517,1159520,1,1,,144211066,4477,Active,,,1.5355,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1518,1159520,1,1,,170465184,4477,Active,,,0.9196,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1519,1159521,1,1,,144211066,4477,Inactive,15928672.0,19885.0,0.0686,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1520,1159521,1,1,,170465184,4477,Inactive,15928672.0,19885.0,0.0461,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1521,1159523,1,1,,144211066,4477,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1522,1159523,1,1,,170465184,4477,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1523,1159524,1,1,,56463356,4477,Active,,,6.3096,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1524,1159524,1,1,,124880876,4477,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1525,1159525,1,1,,144211066,4477,Inconclusive,,,3.8895,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1526,1159525,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1527,1159526,1,1,,144211066,4477,Inconclusive,119627033.0,3725.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1528,1159526,1,1,,170465184,4477,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1529,1159527,1,1,,144211066,4477,Inconclusive,325495497.0,6256.0,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1530,1159527,1,1,,170465184,4477,Inconclusive,325495497.0,6256.0,0.0737,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1531,1159528,1,1,,144211066,4477,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1532,1159528,1,1,,170465184,4477,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1533,1159529,1,1,,144211066,4477,Inconclusive,,,34.6654,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1534,1159529,1,1,,170465184,4477,Inconclusive,,,0.0414,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1535,1159531,1,1,,144211066,4477,Inconclusive,325495497.0,6256.0,0.388952,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1536,1159531,1,1,,170465184,4477,Inconclusive,325495497.0,6256.0,0.6824819999999999,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1537,1159550,3,1,,252401322,4477,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
1538,1159551,1,1,,144211066,4477,Inconclusive,,,1.9331,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1539,1159551,1,1,,170465184,4477,Inconclusive,,,1.0318,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1540,1159552,1,1,,144211066,4477,Inactive,325495463.0,5914.0,0.0686,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1541,1159552,1,1,,170465184,4477,Inactive,325495463.0,5914.0,0.0411,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1542,1159553,2,1,,144211066,4477,Active,325495463.0,5914.0,0.0433,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1543,1159553,2,1,,170465184,4477,Active,325495463.0,5914.0,0.08199999999999999,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1544,1159555,1,1,,144211066,4477,Inconclusive,325495463.0,5914.0,0.0635221,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1545,1159555,1,1,,170465184,4477,Inconclusive,325495463.0,5914.0,0.041077999999999996,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1546,1159580,2,1,,268734940,4477,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1547,1159580,2,1,,273002913,4477,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1548,1159583,2,1,,178127254,4477,Inactive,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
1549,1159606,1,1,,56463356,4477,Active,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1550,1159607,2,1,,312596706,4477,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1551,1159614,1,2,,170465184,4477,Inactive,22328079.0,2581.0,0.3162,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
1552,1159620,1,1,,103516894,4477,Active,,,,,Summary of drug indications.,Other,,
1553,1189129,1,1,,103516894,4477,Active,,,2.49,IC50,"DNDI: Chagas in Vitro, 96 hour",Confirmatory,,
1554,1189130,1,1,,103516894,4477,Active,,,2.3,IC50,"DNDI: Cytotoxicity in Vitro, 72 hour, in rat skeletal myoblast cells",Confirmatory,,
1555,1189131,1,1,,103516894,4477,Active,,,1.01,IC50,"DNDI: Cytotoxicity in Vitro, 96 hour, in mouse macrophages (infected-amastigotes)",Confirmatory,,
1556,1189133,1,1,,103516894,4477,Active,,,1.67,IC50,"DNDI: HAT in Vitro, 72 hour",Confirmatory,,
1557,1189134,1,1,,103516894,4477,Active,,,0.15,IC50,"DNDI: Leish (axenic) in Vitro, 72 hour",Confirmatory,,
1558,1189135,1,1,,103516894,4477,Unspecified,,,0.31,IC50,"DNDI: Leish (macro) in Vitro, 96 hour",Confirmatory,,
1559,1189136,1,1,,103516894,4477,Active,,,1.14,IC50,"DNDI: Malaria in Vitro, 72 hour",Confirmatory,,
1560,1224818,1,1,,312344990,4477,Inconclusive,,,1.1883,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
1561,1224819,1,1,,312344990,4477,Inactive,325495545.0,2101.0,0.0211,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1562,1224820,1,1,,312344990,4477,Active,325495545.0,2101.0,0.0266,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1563,1224821,1,1,,312344990,4477,Inactive,325495545.0,2101.0,0.0237,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1564,1224822,1,1,,312344990,4477,Inconclusive,,,1.3333,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
1565,1224823,1,1,,312344990,4477,Inconclusive,325495545.0,2101.0,0.0422,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1566,1224824,1,1,,174006693,4477,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
1567,1224825,1,1,,174006693,4477,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
1568,1224834,3,1,,144211066,4477,Active,,,3.8571,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1569,1224834,3,1,,170465184,4477,Active,,,1.2990000000000002,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1570,1224835,1,1,,144211066,4477,Active,160794.0,,0.3991,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1571,1224835,1,1,,170465184,4477,Active,160794.0,,0.3011,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1572,1224836,1,1,,144211066,4477,Active,,,6.859,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1573,1224836,1,1,,170465184,4477,Active,,,4.609,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1574,1224837,1,1,,144211066,4477,Active,,,5.4483,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1575,1224837,1,1,,170465184,4477,Active,,,3.2629,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1576,1224838,1,1,,144211066,4477,Inactive,66775687.0,9970.0,1.9331,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1577,1224838,1,1,,170465184,4477,Active,66775687.0,9970.0,4.1078,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1578,1224839,1,1,,144211066,4477,Active,66775687.0,9970.0,1.5355,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1579,1224839,1,1,,170465184,4477,Active,66775687.0,9970.0,0.8196,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1580,1224840,3,1,,144211066,4477,Active,,,2.7306,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1581,1224840,3,1,,170465184,4477,Inconclusive,,,1.4575,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1582,1224841,3,1,,144211066,4477,Inactive,325495545.0,2101.0,0.077,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1583,1224841,3,1,,170465184,4477,Inactive,325495545.0,2101.0,0.0461,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1584,1224842,3,1,,144211066,4477,Active,325495545.0,2101.0,0.077,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1585,1224842,3,1,,170465184,4477,Active,325495545.0,2101.0,0.0517,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1586,1224843,1,1,,144211066,4477,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1587,1224843,1,1,,170465184,4477,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1588,1224844,1,1,,144211066,4477,Inconclusive,,,54.941,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1589,1224844,1,1,,170465184,4477,Inconclusive,,,0.2615,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1590,1224845,1,1,,144211066,4477,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1591,1224845,1,1,,170465184,4477,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1592,1224846,1,1,,144211066,4477,Inconclusive,11995455.0,3091.0,61.6448,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1593,1224846,1,1,,170465184,4477,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1594,1224847,1,1,,144211066,4477,Active,,,2.8385,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1595,1224847,1,1,,170465184,4477,Inconclusive,,,1.5159,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1596,1224848,3,1,,144211066,4477,Inactive,325495545.0,2101.0,0.0969,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1597,1224848,3,1,,170465184,4477,Inactive,325495545.0,2101.0,0.057999999999999996,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1598,1224849,3,1,,144211066,4477,Active,325495545.0,2101.0,0.1087,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1599,1224849,3,1,,170465184,4477,Active,325495545.0,2101.0,0.073,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1600,1224852,2,1,,90341111,4477,Inactive,,,3.8810000000000002,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human neural progenitor cells (hNPCs),Confirmatory,,
1601,1224853,2,1,,90341111,4477,Active,,,1.9451,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1602,1224854,2,1,,90341111,4477,Active,,,1.5451,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytoma cells,Confirmatory,,
1603,1224855,2,1,,90341111,4477,Active,,,1.7336,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1604,1224856,2,1,,90341111,4477,Inconclusive,,,1.7336,Potency,Cell viability assay for measurement of the protective activity of small molecules against cell death caused by Zika virus infection in human astrocytes,Confirmatory,,
1605,1224857,2,1,,170465184,4477,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1606,1224857,2,1,,174006693,4477,Active,,,1.0490000000000002,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1607,1224857,2,1,,312344990,4477,Inconclusive,,,1.0,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1608,1224858,2,1,,90341111,4477,Active,,,1.7336,Potency,Confirmation assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytes,Confirmatory,,
1609,1224859,2,1,,90341111,4477,Active,,,1.0,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1610,1224859,2,1,,170465184,4477,Active,,,2.8184,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1611,1224859,2,1,,174006693,4477,Active,,,1.177,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1612,1224860,2,1,,90341111,4477,Active,,,8.6885,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1613,1224861,2,1,,90341111,4477,Active,,,1.0938,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytes,Confirmatory,,
1614,1224862,2,1,,90341111,4477,Inconclusive,,,15.4505,Potency,Compound cytotoxicity measured by an ATP content assay as a counter-screen for lead compounds in human astrocytoma cell line (SNB-19),Confirmatory,,
1615,1224863,1,1,,316919140,4477,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
1616,1224865,1,2,,56463356,4477,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1617,1224867,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1618,1224867,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1619,1224868,1,1,,144211066,4477,Active,,,3.4665,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1620,1224868,1,1,,170465184,4477,Active,,,0.9277,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1621,1224869,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1622,1224869,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1623,1224870,1,1,,144211066,4477,Inconclusive,,,3.0896,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1624,1224870,1,1,,170465184,4477,Inconclusive,,,1.168,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1625,1224871,1,1,,144211066,4477,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1626,1224871,1,1,,170465184,4477,Active,,,13.1046,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1627,1224872,1,1,,144211066,4477,Inconclusive,,,7.7606,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1628,1224872,1,1,,170465184,4477,Inconclusive,,,1.0409,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1629,1224873,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1630,1224873,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1631,1224874,1,1,,144211066,4477,Active,,,2.1872,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1632,1224874,1,1,,170465184,4477,Active,,,0.8268,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1633,1224875,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1634,1224875,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1635,1224876,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1636,1224876,1,1,,170465184,4477,Active,,,0.0293,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1637,1224877,1,1,,144211066,4477,Inconclusive,,,2.7536,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1638,1224877,1,1,,170465184,4477,Inconclusive,,,1.0409,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1639,1224878,1,1,,144211066,4477,Active,,,5.4941,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1640,1224878,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1641,1224879,1,1,,144211066,4477,Active,,,4.8966,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1642,1224879,1,1,,170465184,4477,Active,,,2.3304,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1643,1224880,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1644,1224880,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1645,1224881,1,1,,144211066,4477,Active,,,38.8952,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1646,1224881,1,1,,170465184,4477,Inconclusive,,,14.7036,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1647,1224882,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1648,1224882,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1649,1224883,1,1,,144211066,4477,Active,,,4.8966,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1650,1224883,1,1,,170465184,4477,Active,,,2.9338,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1651,1224884,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1652,1224884,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1653,1224885,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1654,1224885,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1655,1224886,1,1,,144211066,4477,Active,,,5.4941,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1656,1224886,1,1,,170465184,4477,Active,,,1.0409,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1657,1224887,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1658,1224887,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1659,1224888,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1660,1224888,1,1,,170465184,4477,Inactive,,,6.5679,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1661,1224889,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1662,1224889,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1663,1224890,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1664,1224890,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1665,1224892,1,1,,144211066,4477,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1666,1224892,1,1,,170465184,4477,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1667,1224893,1,1,,144211066,4477,Inconclusive,66775687.0,9970.0,1.08707,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1668,1224893,1,1,,170465184,4477,Inconclusive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1669,1224894,1,1,,144211066,4477,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1670,1224894,1,1,,170465184,4477,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1671,1224895,1,1,,144211066,4477,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1672,1224895,1,1,,170465184,4477,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1673,1224896,1,1,,144211066,4477,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1674,1224896,1,1,,170465184,4477,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1675,1224905,2,1,,121361717,4477,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1676,1224905,2,1,,121361717,4477,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1677,1241255,1,1,,103516894,4477,Active,,,,,Inhibition of Wnt/beta-catenin in human U2OS cells assessed as internalization of frizzled-GFP at 12.5 uM after 6 hrs by confocal microscopic analysis,Other,26272032.0,
1678,1241256,1,1,,103516894,4477,Active,,,0.34,IC50,Inhibition of Wnt/beta-catenin in HEK293 cells assessed as inhibition of Wnt3A-stimulated TOPFlash activity after 8 hrs,Confirmatory,26272032.0,
1679,1241257,1,1,,103516894,4477,Unspecified,,,,,Inhibition of Wnt/beta-catenin in human HCT116 cells assessed as remaining cytosolic beta-catenin level at 2 uM after 18 hrs by Western blot analysis relative to control,Other,26272032.0,
1680,1241259,1,1,,103516894,4477,Active,,,0.45,IC50,Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTS assay,Confirmatory,26272032.0,
1681,1241260,1,1,,103516894,4477,Unspecified,,,,,Oral bioavailability in Sprague-Dawley rat at 5 mg/kg,Other,26272032.0,
1682,1241261,1,1,,103516894,4477,Unspecified,,,,,"Total clearance in Sprague-Dawley rat at 2 mg/kg, iv",Other,26272032.0,
1683,1241262,1,1,,103516894,4477,Unspecified,,,,,"Volume of distribution at steady state in Sprague-Dawley rat at 2 mg/kg, iv",Other,26272032.0,
1684,1241263,1,1,,103516894,4477,Unspecified,,,,,"Half life in Sprague-Dawley rat at 2 mg/kg, iv",Other,26272032.0,
1685,1241264,1,1,,103516894,4477,Active,,,,,"Drug uptake in plasma of CD1 mouse at 200 mg/kg, po by LC/MS-MS analysis",Other,26272032.0,
1686,1241266,1,1,,103516894,4477,Unspecified,,,,,"Drug level in CD1 mouse plasma treated with DK-520 at 200 mg/kg, po measured for 24 hrs by LC/MS-MS analysis",Other,26272032.0,
1687,1241276,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human breast cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1688,1241277,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human colon cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1689,1241278,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human lung cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1690,1241279,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human prostate cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1691,1241280,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human ovarian cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1692,1241281,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human blood cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1693,1241282,1,1,,103516894,4477,Active,,,0.13,IC50,Cytotoxicity against human pancreatic cancer cells assessed as growth inhibition after 72 hrs by Cell Titer Glo Assay,Confirmatory,26272032.0,
1694,1241283,1,1,,103516894,4477,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,26272032.0,
1695,1241284,1,1,,103516894,4477,Unspecified,,,,,"Lipophilicity, log P of the compound at pH <=4",Other,26272032.0,
1696,1241285,1,1,,103516894,4477,Unspecified,,,,,"Distribution coefficient, log D of the compound at pH 7",Other,26272032.0,
1697,1259241,1,1,,144211066,4477,Inconclusive,,,1.7229,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1698,1259241,1,1,,170465184,4477,Inconclusive,,,1.0318,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1699,1259242,1,1,,144211066,4477,Active,,,2.169,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1700,1259242,1,1,,170465184,4477,Active,,,1.4575,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1701,1259243,1,1,,144211066,4477,Active,124375976.0,367.0,1.9331,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1702,1259243,1,1,,170465184,4477,Active,124375976.0,367.0,1.2990000000000002,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1703,1259244,1,1,,144211066,4477,Active,348019627.0,2099.0,2.4337,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1704,1259244,1,1,,170465184,4477,Active,348019627.0,2099.0,1.6353,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1705,1259247,1,1,,144211066,4477,Inconclusive,124375976.0,367.0,2.25385,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1706,1259247,1,1,,170465184,4477,Inconclusive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1707,1259248,1,1,,144211066,4477,Inconclusive,348019627.0,2099.0,2.08733,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1708,1259248,1,1,,170465184,4477,Active,348019627.0,2099.0,1.2030299999999998,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1709,1259252,1,1,,174006693,4477,Active,169655958.0,,16.6261,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
1710,1259253,1,1,,174006693,4477,Active,169655958.0,,1.3207,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
1711,1259255,1,1,,174006693,4477,Active,169655958.0,,16.6261,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
1712,1259256,1,1,,174006693,4477,Active,169655958.0,,1.3207,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
1713,1259309,1,1,,178127254,4477,Active,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
1714,1259310,1,1,,321942667,4477,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1715,1259310,1,1,,332950229,4477,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1716,1259310,1,1,,332950418,4477,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1717,1259311,1,1,,178127254,4477,Active,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
1718,1259313,1,1,,56463356,4477,Active,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1719,1259318,1,1,,56463356,4477,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1720,1259333,1,1,,56463356,4477,Inactive,,,7.0,AC50_uM,"7124-04: Celltiter Glo, Cytotoxicity assay",Other,,
1721,1259334,1,1,,56463356,4477,Inactive,,,,AC50_uM,"7124-02: inhibition of TNFa signaling in B cell lineage, counterscreen",Other,,
1722,1259344,1,1,,144203760,4477,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
1723,1259354,1,1,,348429915,4477,Inactive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
1724,1259355,1,1,,26753613,4477,Active,,,3.9811,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
1725,1259356,1,1,,144203760,4477,Inconclusive,,,2.31,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
1726,1259364,1,1,,144211066,4477,Active,1013403374.0,9734.0,0.9689,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1727,1259364,1,1,,170465184,4477,Active,1013403374.0,9734.0,0.5802,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1728,1259365,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1729,1259365,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1730,1259366,1,1,,144211066,4477,Active,,,68.5896,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1731,1259366,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1732,1259367,1,1,,144211066,4477,Active,,,30.6379,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1733,1259367,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1734,1259368,1,1,,144211066,4477,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1735,1259368,1,1,,170465184,4477,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1736,1259369,1,1,,144211066,4477,Inconclusive,109731339.0,2737.0,5.4483,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1737,1259369,1,1,,170465184,4477,Inconclusive,109731339.0,2737.0,11.5774,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1738,1259370,2,2,,124637475,4477,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1739,1259370,2,2,,124637475,4477,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1740,1259370,2,2,,124637475,4477,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1741,1259377,1,1,,144211066,4477,Inconclusive,54288833.0,2100.0,4.8558,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1742,1259377,1,1,,170465184,4477,Inconclusive,54288833.0,2100.0,5.8024,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1743,1259378,1,1,,144211066,4477,Inconclusive,54288833.0,2100.0,34.3762,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1744,1259378,1,1,,170465184,4477,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1745,1259379,1,1,,144211066,4477,Active,,,1.9331,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1746,1259379,1,1,,170465184,4477,Active,,,1.4575,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1747,1259380,1,1,,144211066,4477,Active,,,8.6349,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1748,1259380,1,1,,170465184,4477,Active,,,0.092,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1749,1259381,1,1,,144211066,4477,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1750,1259381,1,1,,170465184,4477,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1751,1259382,1,1,,144211066,4477,Active,,,2.169,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1752,1259382,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1753,1259383,1,1,,144211066,4477,Active,348019627.0,2099.0,0.077,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1754,1259383,1,1,,170465184,4477,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1755,1259384,1,1,,144211066,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1756,1259384,1,1,,170465184,4477,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1757,1259385,1,1,,144211066,4477,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1758,1259385,1,1,,170465184,4477,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1759,1259386,1,1,,144211066,4477,Active,,,1.3685,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1760,1259386,1,1,,170465184,4477,Active,,,1.2990000000000002,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1761,1259387,1,1,,144211066,4477,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1762,1259387,1,1,,170465184,4477,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1763,1259388,1,1,,144211066,4477,Active,1013403374.0,9734.0,0.897274,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1764,1259388,1,1,,170465184,4477,Active,1013403374.0,9734.0,0.497672,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1765,1259389,1,1,,124637475,4477,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1766,1259390,1,1,,144211066,4477,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1767,1259390,1,1,,170465184,4477,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1768,1259391,1,1,,144211066,4477,Active,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1769,1259391,1,1,,170465184,4477,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1770,1259392,1,1,,144211066,4477,Inconclusive,109731339.0,2737.0,12.6743,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1771,1259392,1,1,,170465184,4477,Active,109731339.0,2737.0,7.887569999999999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1772,1259393,1,1,,144211066,4477,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1773,1259393,1,1,,170465184,4477,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1774,1259394,1,1,,144211066,4477,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1775,1259394,1,1,,170465184,4477,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1776,1259395,1,1,,144211066,4477,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1777,1259395,1,1,,170465184,4477,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1778,1259396,1,1,,144211066,4477,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1779,1259396,1,1,,170465184,4477,Inconclusive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1780,1259400,1,1,,170465184,4477,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
1781,1259401,1,1,,144211066,4477,Inconclusive,325495545.0,2101.0,0.07695880000000001,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1782,1259401,1,1,,170465184,4477,Inconclusive,325495545.0,2101.0,0.033906,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1783,1259402,1,1,,144211066,4477,Active,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1784,1259402,1,1,,170465184,4477,Active,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1785,1259403,1,1,,144211066,4477,Inconclusive,325495545.0,2101.0,0.0685896,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1786,1259403,1,1,,170465184,4477,Inconclusive,325495545.0,2101.0,0.0497672,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1787,1259404,1,1,,144211066,4477,Active,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1788,1259404,1,1,,170465184,4477,Active,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1789,1259407,1,1,,363901387,4477,Active,,,,,CCRIS mutagenicity studies,Other,,
1790,1259408,1,1,,363894766,4477,Active,,,,,GENE-TOX mutagenicity studies,Other,,
1791,1259415,1,1,,56463356,4477,Active,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
1792,1259416,1,2,,340080306,4477,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1793,1259416,1,2,,375174656,4477,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1794,1259421,1,1,,340080306,4477,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1795,1259421,1,1,,375174656,4477,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1796,1259423,1,2,,354776823,4477,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1797,1259423,1,2,,354815542,4477,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1798,1259423,1,2,,354838096,4477,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
